pmid doi title abstract year month day

38236558 10.1007/s119PARP InhibitoIn the last d 2024 1 18

38236447 10.1007/s1108-Br-cGMP sup Cyclic guanos 2024 1 18
38236435 10.1007/s107Correction: CNA 2024 1 18
38235574 10.1080/147 Myricetin, a nOvarian cance 2024 1 18
38235148 10.3389/fim Case report: Treatment for 2024 1 18
38235131 10.3389/fim NLRC5 overexp Epithelial ov 2024 1 18
38234891 10.1016/j.he Aberrant miR-Ovarian cance 2024 1 18
38234717 10.1101/2023Mapping inher Germline alle 2024 1 18
38234667 10.22038/IJB <i>In vitro</i Harmaline and 2024 1 18
38234609 10.3892/etm.Comprehensive Neuropilin 1 2024 1 18
38234385 10.1016/j.eu An uncommon Soft
c tissue s 2024 1 18
38233938 10.1186/s130The prevention Rectovaginal 2024 1 17
38233863 10.1186/s129Tumor-derived Omental metas 2024 1 17
38233093 10.1136/ijgc Who takes carNA 2024 1 17
38232985 10.1021/acs. Immunotherapy Ovarian cance 2024 1 17
38232611 10.1016/j.es Is controlled Controlled ov 2024 1 17
38231530 10.17305/bb.Advances in nAdvanced ovar 2024 1 17
38231483 10.1158/1078Preclinical e DNA methylati 2024 1 17
38230850 10.1002/camPhenotype ana Tumor protein 2024 1 17
38230764 10.1002/camBiomarkers ofThe mortality 2024 1 17
38230704 10.1097/GRFImproving theBeing a gynec 2024 1 17
38230565 10.1002/cnr2SMAD4 inhibitARHGAP10 is a 2024 1 17
38230369 10.1117/1.JB Mini review oPhotoacoustic 2024 1 18
38230225 10.7150/jca. The Effective Obesity and c 2024 1 18
38230220 10.7150/jca. Unraveling th<b>Objective: 2024 1 18
38230199 10.1155/202 Retracted: SP[This retract 2024 1 18
38229838 10.21037/gs-Secondary cytSecondary cyt 2024 1 18
38229045 10.1186/s128Long-term outRecently, wit 2024 1 18
38228517 10.3760/cma.[Swyer syndro<b>Objective 2024 1 18
38227666 10.1073/pna Tumor resistaDespite many 2024 1 18
38227082 10.1007/s110Co-treatmentOvarian
o cance 2024 1 17
38226979 10.18632/agiIdentificatio Anoikis, a fo 2024 1 16
38226658 10.1039/d3a Ultrasensitiv MicroRNAs (mi 2024 1 16
38226451 10.1111/cas. Altered tumorChemotherapy 2024 1 16
38226182 10.2147/IJGMAssociation BTo investigat 2024 1 17
38226168 10.1016/j.isc Deep learningProtein glyco 2024 1 17
38225646 10.1186/s130Virus-like pa MUC16 is a he 2024 1 17
38225339 10.1038/s413Ascites exosoCisplatin res 2024 1 15
38223825 10.1016/j.jgr Ginsenoside 2Ginsenoside 2 2024 1 16
38223583 10.4314/ahs.Mir-21 and MiOvarian cance 2024 1 16
38223534 10.2147/IMCRBRCA2, PALB2, Multiple prim 2024 1 16
38223308 10.1016/j.mbOmentum-deriv High-grade se 2024 1 16
38223064 10.21037/qimPredicting epIdentifying r 2024 1 16
38222766 10.1097/MS9Mixed connect Mixed connect 2024 1 16
38222355 Transferable Ovarian cance 2024 1 16
38222172 10.7759/cureMucinous Cyst Mucinous cyst 2024 1 16
38221766 10.1111/ajcoDiagnostic ef To enhance ov 2024 1 15
38221679 10.1177/109 First Reporte A 43-year-old 2024 1 15
38219858 10.1016/j.jo Melatonin and The progress 2024 1 14
38219700 10.1016/j.ej Peritonectomy To describe t 2024 1 14
38219610 10.1016/j.ejoThe Gustave RThis study wa 2024 1 14
38219492 10.1016/j.pr Germline muta Hereditary Br 2024 1 14
38219331 10.1016/j.jg Impact of ageCancer incide 2024 1 14
38219077 10.1002/jcp. Bitter taste Type 2 taste 2024 1 14
38218807 10.1186/s129Comprehensive Both mitophag 2024 1 15
38218775 10.1186/s129Efficacy and Almost all pa 2024 1 15
38218208 10.1016/j.cri The role of li The clinical 2024 1 13
38217326 10.1080/147 <i>De novo</i<i>Caesalpini 2024 1 13
38216951 10.1186/s130The regulatioOvarian cance 2024 1 15
38216776 10.1007/s430Ovarian StimuUterine fluid 2024 1 12
38216775 10.1007/s430Fertility-Spa Primary mucin 2024 1 12
38216684 10.1038/s415Nanoreceptors In some cance 2024 1 12
38216547 10.4103/ijc.I Role of Serin Serine-Argini 2024 1 12
38216278 10.1016/j.tjo Ovarian clear Ovarian clear 2024 1 15
38216253 10.1016/j.tjo Comment on NA th 2024 1 15
38216242 10.1016/j.tjo Front-line ch In the Part I 2024 1 15
38216136 10.3802/jgo. Preoperative Pl atients with 2024 1 12
38216134 10.3802/jgo. Confirmation The o modeled C 2024 1 12
38216120 10.1016/j.lfs Role of p53 trTelomerase ex 2024 1 14
38215600 10.1016/j.ejoCounselling aTo review the 2024 1 12
38215549 10.1016/j.ej Secondary cytTo evaluate t 2024 1 12
38215536 10.1016/j.jin Dinuclear copA bis(chalcon 2024 1 12
38215513 10.1016/j.yg Germline andGermline and 2024 1 12
38215419 Adnexal MassPelvic masses 2024 1 15
38215359 10.1200/JCO.Poor Concorda Cancer antige 2024 1 12
38215174 10.1371/jourNon-canonicalDeubiquitinas 2024 1 12
38214845 10.1007/s106Vitamin D andWe summarized 2024 1 12
38214580 10.1158/1055MitochondrialMitochondrial 2024 1 12
38214491 10.1021/acssTandem SERSExtracellular
a 2024 1 12
38214360 10.2174/157 Circ_0070203Circular RNAs 2024 1 15
38214315 10.3892/ijo. Targeting endDespite signi 2024 1 15
38213732 10.7150/jca. A concise revRecent studie 2024 1 13
38212905 10.1002/ijc.3Trps1 predictTRPS1 is aber 2024 1 12
38212795 10.1186/s129ANGPTL4 accel Ovarian cance 2024 1 15
38212751 10.1186/s129Elevated serum Carbohydrate 2024 1 15
38212232 10.1016/S258Artificial int Ovarian cance 2024 1 11
38212229 10.1016/j.patPredictive andThe evaluatio 2024 1 11
38212226 10.1016/j.asj Primary pulmoNA 2024 1 11
38212069 10.2967/jnum[<sup>68</suNA 2024 1 11
38212017 10.19540/j.c [Advances in Ovarian cance 2024 1 15
38211842 10.1016/j.celALDH1A3 contr High-grade se 2024 1 14
38211832 10.1016/j.fr MARCH5-mediat Lipid metabol 2024 1 13
38211405 10.1016/j.yg Prognosis andAn important 2024 1 11
38207205 10.1158/2767Exploring co- POLE driver m 2024 1 11
38206277 10.1200/GO. Systemic TreaTo guide clin 2024 1 12
38205842 10.1002/ijgo Do survivors To describe t 2024 1 11
38205802 10.1158/153 Raludotatug DCadherin-6 (C 2024 1 11
38205117 10.1007/s132OOPHORECTOMY: The decision 2024 1 12
38205105 10.1007/s132Ovarian CarciNA 2024 1 12
38204939 10.1093/hro Influence of Do ovarian st 2024 1 12
38203818 10.3390/ijmsNanoparticle-Epirubicin hy 2024 1 12
38203758 10.3390/ijmsRole of SLC7AOvarian cance 2024 1 12
38203692 10.3390/ijmsComprehensive Molecules int 2024 1 16
38203684 10.3390/ijmsTranscriptomiOvarian cance 2024 1 12
38203494 10.3390/ijmsEnhancing Imm Ovarian cance 2024 1 12
38203451 10.3390/ijmsBioactive Pro<i>Tagetes er 2024 1 12
38203374 10.3390/ijmsBRCA Mutation Hereditary ca 2024 1 12
38203310 10.3390/ijmsLong Non-Codi Ovarian cance 2024 1 12
38203280 10.3390/ijmsMitogen-ActivMitogen-activ 2024 1 12
38202856 10.3390/mol Pan-EGFR InhiPaclitaxel is 2024 1 12
38201645 10.3390/cancNew <i>N</i>-The conjugate 2024 1 14
38201617 10.3390/cancDysregulationSurgical trea 2024 1 14
38201604 10.3390/cancReal-World CoPatients diag 2024 1 14
38201589 10.3390/cancRelapsed Ovar(1) Backgroun 2024 1 14
38201563 10.3390/cancGenomic Lands This study ai 2024 1 14
38201534 10.3390/cancSynergistic S Ovarian cance 2024 1 14
38201529 10.3390/cancProphylactic Hereditary br 2024 1 14
38201519 10.3390/cancFirst-in-Huma(1) Backgroun 2024 1 14
38201508 10.3390/cancCyclooxygenas Chronic infla 2024 1 14
38201503 10.3390/cancAnalysis of A Patients with 2024 1 14
38201470 10.3390/cancMITO39: EfficWhile PLD-Tra 2024 1 14
38201468 10.3390/cancThe Role of COvarian cance 2024 1 14
38201403 10.3390/diagExplaining th There is no w 2024 1 11
38201315 10.3390/diagPrediction of Ovarian metas 2024 1 11
38201211 10.3390/cell A Microfluidi Among cancer 2024 1 12
38200255 10.1038/s415Insights for The Cancer Pr 2024 1 10
38200105 10.1038/s415EffectivenessAim of the pr 2024 1 12
38199811 10.1136/oemAgricultural Ovarian cance 2024 1 10
38199479 10.1016/j.ye MAPRE3 as anOvarian
e cance 2024 1 15
38199050 10.1016/j.jin Antitumor actUtilizing iso 2024 1 10
38197954 10.1007/s002Surgical evid Imaging asses 2024 1 10
38197671 10.1158/2767A revised molThe biomarker 2024 1 10
38196540 10.21037/jgoDurable respoCholangiocarc 2024 1 11
38196068 10.1007/s113Cell-free asc Ascites plays 2024 1 10
38195887 10.1038/s414AutoantibodieMultiple anti 2024 1 10
38195842 10.1038/s420SH3RF2 contriPlatinum-base 2024 1 11
38195606 10.1038/s414CRABP2 affectOvarian cance 2024 1 16
38195246 10.1093/biol Sodium thiosuCisplatin, a 2024 1 9
38194739 10.1016/j.bi Copper nitropThe clinical 2024 1 9
38194613 10.1200/JCO.Normal Risk OThe Normal Ri 2024 1 9
38193640 10.1002/ctm2Mutational prEpithelial ov 2024 1 10
38193330 10.3346/jkmsA Successful This article 2024 1 10
38193139 10.2147/IJW The High SensWe evaluated 2024 1 10
38193129 10.1002/btmStatic magnetOvarian tissu 2024 1 10
38192954 10.7759/cureFilling the Ga With enhanced 2024 1 10
38192656 10.3892/ol.2 Non&#x2011;sy Primary small 2024 1 10
38192647 10.3389/fnutAssociation bThe intricate 2024 1 10
38192593 10.1016/j.ec Combined popu No previous h 2024 1 10
38192229 10.1111/1747Mental healthTo investigat 2024 1 9
38192153 10.1177/153 Suppression o<b>Background 2024 1 10
38191909 10.1038/s416Cancer associFrequent rela 2024 1 11
38191799 10.1038/s415FGL2 promotes The tumour mi 2024 1 10
38191790 10.1007/s406The "Strong BThe strong Bl 2024 1 8
38191387 10.1186/s129Long-term outDue to the ab 2024 1 10
38191325 10.1186/s128Ovarian canceMost cancer p 2024 1 10
38191019 10.1016/j.ajoSerial cytore Few studies h 2024 1 8
38190969 10.1016/j.gof[News in breaBreast oncolo 2024 1 8
38190584 10.1200/OP.2Disparities i National Canc 2024 1 8
38190309 10.1089/jwh.Ovarian InsufThe term "ova 2024 1 8
38190278 10.1089/bfm.Prenatal Coun<b><i>Objecti 2024 1 8
38189344 10.1080/073 Identificatio The aldehyde 2024 1 8
38189098 10.1039/d3d Synthesis andMitophagy, a 2024 1 8
38188470 10.1177/175 Combined useAnlotinib is 2024 1 9
38188465 10.1177/175 High CTLA-4 tCTLA-4 impede 2024 1 9
38188462 10.1177/175 ZolbetuximabClaudins (CLD 2024 1 9
38188285 10.3389/foncA tumor-restrTargeted-immu 2024 1 9
38187851 10.1007/s131A Review of CThe number of 2024 1 9
38187845 10.1007/s131Synchronous W a omen with ei 2024 1 9
38187842 10.1007/s131Clinical Obse Low-grade ser 2024 1 9
38187402 10.3389/fim Ovarian canceOvarian cance 2024 1 9
38187310 10.1016/j.he Phenotype-gui Ovarian cance 2024 1 9
38187063 Increased expTumor hypoxia 2024 1 9
38187059 Genetic estimThe controver 2024 1 9
38186978 Combinational In recent yea 2024 1 9
38186770 10.4103/jfmpBevacizumab Earlier,
c pati 2024 1 9
38186569 10.32604/or.TGF-&#x3b2;-r The impact of 2024 1 9
38185864 10.4103/ijc.I Survival outcoOne needs to 2024 1 12
38185807 10.1111/1759Prognostic fa Hormone recep 2024 1 7
38185688 10.1186/s130Rare copy-num Copy-number v 2024 1 9
38185058 10.1016/j.tr HeterogeneityChemotherapy 2024 1 15
38184808 10.1007/s120Mechanism ofTo investigat 2024 1 7
38184614 10.1186/s130A novel targeDeleterious m 2024 1 8
38184597 10.1186/s129N6-methyladen Cisplatin (CD 2024 1 8
38184581 10.1186/s400ER-positive a BRCA2-mutated 2024 1 8
38184072 10.1016/j.jv Quantificatio Digital PCR ( 2024 1 6
38183864 10.1016/j.ej CollaborativeMost patients 2024 1 6
38183316 10.1111/aogsGynecologicalGynecological 2024 1 6
38183176 10.1177/030 Is motherhood Preserving th 2024 1 6
38182756 10.1038/s420Single-cell a High-grade se 2024 1 8
38182734 10.1038/s416Autosurv: int Accurate prog 2024 1 15
38182548 10.1111/cas. LINC00629, a Ovarian cance 2024 1 5
38181933 10.1016/j.je Danggui Shaoy It has been r 2024 1 7
38181927 10.1016/j.ge L-Carnitine faCyclophospham 2024 1 5
38181892 10.1016/j.bb HERC4 modulat HERC4 has bee 2024 1 5
38181438 10.1210/clin Cardiometabol Menopause is 2024 1 5
38181291 10.1097/MD.Comparative A a mong all gyn 2024 1 12
38180587 10.1007/s105A disposable Cancer antige 2024 1 8
38179758 10.31083/j.f RIPK4 Promote To investigat 2024 1 9
38179550 10.1159/000 Primary PeritMalignant mix 2024 1 6
38179400 10.7759/cureOvarian TeratGliomatosis p 2024 1 6
38179264 10.14309/crj Rare MetastasEsophageal ca 2024 1 6
38179228 10.1016/j.mt Thiol-yne clicThere is a gr 2024 1 6
38178704 10.3802/jgo. Clinical guid Since the lat 2024 1 17
38178703 10.3802/jgo. Cerebral infa The combinati 2024 1 5
38178702 10.3802/jgo. Prevention o In Japan, per 2024 1 5
38178252 10.1186/s130Exosomal biom Investigating 2024 1 8
38178203 10.1186/s130High-expresseAcetyl-CoA ac 2024 1 11
38178187 10.1186/s130A risk model Ovarian cance 2024 1 8
38178060 10.1186/s128EndometrioidEndometrioid 2024 1 8
38177412 10.1038/s413Loss of LECT2Leukocyte cel 2024 1 4
38177053 10.1016/j.cpePET/Computed Over the last 2024 1 4
38176127 10.1016/j.yg Prognostic vaTo assess the 2024 1 4
38176019 10.1097/AOGEarly OvarianTo determine 2024 1 4
38175731 10.1172/jci.i Evolutionary Dissemination 2024 1 4
38175694 10.18632/agiManganese and Metal immunot 2024 1 4
38175687 10.18632/agiSignatures ofOvarian cance 2024 1 4
38174903 10.1002/cncrEstimation ofGenetic, life 2024 1 4
38174862 10.1002/mc. ITGA7 loss drCancer-associ 2024 1 4
38174379 10.1080/147 Comparison of Poly(adenosin 2024 1 4
38174205 10.7759/cureEmerging Appl Liquid biopsy 2024 1 5
38173116 10.3881/j.is [MRI FindingsUterine tumo 2024 1 5
38173064 10.2174/011 Real-world StThis study in 2024 1 4
38172961 10.1186/s130Ovarian non-gWe previously 2024 1 5
38172843 10.1186/s129Prognostic and Many studies 2024 1 5
38172678 10.1186/s120Quantificatio Ovarian cance 2024 1 6
38172536 10.1038/s438Computational The role of i 2024 1 6
38172449 10.1007/s118Antibody-Drug Antibody-drug 2024 1 3
38172397 10.1038/s416Comparing mo NA 2024 1 8
38172241 10.1038/s415¹⁸ The objective 2024 1 5
38171920 10.48095/cccMethods and:tObjective: E 2024 1 5
38171885 10.1002/pmi Proteomic proClear cell ov 2024 1 3
38171036 10.1016/j.jri Frequent exprSeminoma and 2024 1 3
38170620 10.1097/GCOThe evolving This review a 2024 1 3
38170549 10.1097/GCOA review of raOvarian cancer 2024 1 5
38170548 10.1097/GCOMaintenance Epithelial
t ov 2024 1 5
38170294 10.1007/s110A benzimidazol Ovarian cancer 2024 1 5
38169995 10.2147/IJN. Combination Coombination t 2024 1 5
38169739 10.1016/j.he Protective rolPremature ovar 2024 1 5
38169730 10.3389/foncLiquid biopsy Ovarian cance 2024 1 5
38169558 10.7150/jca. Impact of Tre<b>Purpose:</ 2024 1 5
38169546 10.7150/jca. Comprehensive <b>Background 2024 1 5
38169532 10.7150/ijbs Selectively taOvarian cance 2024 1 5
38169324 10.1080/155 DIRAS3 induce Pancreatic du 2024 1 3
38168858 10.1007/s003Germline BRCA BRCA1 and BRC 2024 1 3
38168673 10.1038/s415Alterations i Metabolic alt 2024 1 5
38168227 10.21203/rs. Transgelin 2 Mounting effe 2024 1 9
38168194 10.1101/2023Saturation gen Germline BRCA 2024 1 3
38168186 10.1101/2023Engineering se Chimeric anti 2024 1 15
38167649 10.1038/s415MAD2L2, a key Ovarian cance 2024 1 5
38167159 10.1186/s129Interplay of Cancer remain 2024 1 5
38166898 10.1186/s129Prognostic and Breast cancer 2024 1 5
38166810 10.1186/s129Prognostic fa Several studi 2024 1 5
38166752 10.1186/s128The emergingLong non-codi 2024 1 17
38166549 10.1080/016 Blood Lipid MObservational 2024 1 18
38166541 10.1186/s128Single-cell anThere has bee 2024 1 4
38165945 10.1371/jourEfficacy of p Lymphaticoven 2024 1 4
38165032 10.1172/JCI1 Biology-driveFollowing a p 2024 1 3
38165547 10.1007/s110CCT2 prevente Epithelial ov 2024 1 4
38164343 10.1177/263 Ethnic dispar Ethnic dispar 2024 1 3
38164137 10.7150/thnoMK8722 initia<b>Background 2024 1 3
38164130 10.3389/fim Targeting theOvarian cance 2024 1 3
38163482 10.1016/j.jc Germline gene Hepatobiliary 2024 1 1
38162662 10.3389/fim Deciphering tElevated CA-1 2024 1 3
38162618 10.3389/fpubA cost-utility Screening for 2024 1 3
38161785 10.1016/j.aj A nanocomposi Ovarian cance 2024 1 3
38160209 10.1007/s430In Vitro MatuThis paper wi 2023 12 30
38160182 10.1016/j.be Post cancer cNA 2023 12 30
38160042 10.1136/jmg-Clinical impli <i>BRCA1/2</i 2023 12 30
38159938 10.1136/ijgc Secondary cytPoly ADP-ribo 2023 12 30
38159467 10.1016/j.rb Progestin-pri Progestin-pri 2023 12 30
38159362 10.1016/j.yg Determining tTo determine 2023 12 30
38159206 10.5603/ep.9Ovarian metasNo required fo 2024 1 3
38159086 10.1093/oncoA Novel GermlThe presence 2023 12 30
38158767 10.1111/iwj. Enhancing wou Ovarian cance 2023 12 30
38158678 10.14715/cmb An investigat Follicular de 2024 1 3
38156990 10.1016/j.gi Response to SNA 2023 12 29
38156862 10.31557/APJD-dimer, FibrLimited studi 2024 1 3
38156104 10.3389/foncAnalysis of t Ovarian cance 2023 12 30
38155625 10.18999/nagA case of sim We experience 2024 1 1
38155475 10.1111/his. Infiltrative Mucinous ovar 2023 12 29
38155449 10.4103/ijc.I Survival anal This study in 2023 12 29
38155066 10.1016/j.jn ElectroconvulAnti-NMDAR en 2024 1 15
38154527 10.1016/j.ymA near-infrar &#x3b2;-Galac 2023 12 30
38154497 10.1016/j.la Fibroblast Gr With more nov 2023 12 28
38154365 10.1016/j.vhrEconomic EvalIn the absenc 2023 12 28
38154356 10.1016/j.pr METTL3/YTHDF Ovarian cance 2023 12 28
38154269 10.1016/j.bi Adeno-associaGelatin-based 2024 1 10
38153260 10.1080/194 Gut microbiom Women are at 2023 12 29
38152652 10.3389/fgenThe role of ci Ovarian cance 2023 12 29
38152363 10.3389/foncEffectivenessTo evaluate t 2023 12 29
38152134 10.3389/fendChinese ExperCervical canc 2023 12 29
38151891 10.1111/iwj. Effect of bev In this meta- 2023 12 28
38151625 10.1038/s430Small-moleculChromosomal i 2023 12 27
38151326 10.1101/cshpGermline Gene Our understan 2023 12 27
38150880 10.1016/j.in PD-1 and TIGIImmunotherapy 2024 1 18
38150838 10.1016/j.yg A dramatic reWe present th 2023 12 27
38150837 10.1016/j.yg DevelopmentIna this study 2023 12 27
38150241 10.1001/jamaTest Using RoNA 2024 1 17
38150120 10.1007/s402An ExploratorDetermining w 2023 12 27
38149570 10.1016/j.in Lactate inhib The emergence 2023 12 28
38149473 10.1002/2211Retraction: KiKinesin famil 2023 12 27
38149072 10.4322/acr. Ovarian hydatHydatid cyst 2023 12 28
38148465 10.1007/s120The emergingBreast cancer 2023 12 28
38148089 10.21873/invPlatinum-freeWe investigat 2023 12 28
38148044 10.21873/invCurrent PositFertility pres 2023 12 28
38148043 10.21873/invPD-L1 and PD-Immune checkp 2023 12 28
38147713 10.1016/j.yg Associations To evaluate t 2023 12 26
38147479 10.2478/acphBeliefs aboutThis observat 2023 12 28
38147209 10.1007/978-OT-I TCR TranPhosphotyrosi 2023 12 27
38147070 10.18632/oncOne more step NA 2023 12 27
38147061 10.1158/1055Physical Act Dense breast 2023 12 26
38146865 10.1002/cbic Novel bidentatPt(II) and Pd 2023 12 26
38146633 10.1002/ijgo Recurrent ovaTo determine 2023 12 26
38146509 10.3389/foncOptimized com Complete macr 2023 12 27
38146508 10.3389/foncThe emergence BRCA1 is invo 2023 12 27
38146364 10.3389/fim CAR-T cell imAs the most l 2023 12 27
38145439 10.1007/s105Air quality anThe NIH All o 2023 12 25
38144904 10.2147/OTTInhibition of Endometrial c 2023 12 25
38144668 10.1016/j.ommiR-146a: Ove NA 2023 12 25
38144530 10.3389/foncThe research Synchronous e 2023 12 25
38144130 10.1021/acs Comprehensive Extracellular 2023 12 25
38143997 10.1007/s132Ectopic OculaTeratomas are 2023 12 25
38143926 10.3389/fcel Plasminogen <ab>Introducti 2023 12 25
38143770 10.3389/fim Multifactor a Ovarian cance 2023 12 26
38143502 10.3389/fphaThe role of k Kaempferol, a 2023 12 25
38142239 10.1093/humEndometriosisDo severe end 2023 12 23
38141599 10.1055/s-00Systemic Infl &#x2003;To co 2023 12 25
38141516 10.1016/j.jri Moesin affectAmong major h 2023 12 23
38140910 10.1096/fj.2 Erratum to "TaNA 2024 1 8
38140698 10.1002/cac2Rescue of p53The cellular 2024 1 18
38140230 10.3390/vaccAgonistic Biv (1) Backgroun 2023 12 25
38139406 10.3390/ijmsCopper in GynCopper (Cu) i 2023 12 25
38139364 10.3390/ijmsOncoTherad<su This study as 2024 1 11
38139300 10.3390/ijmsmiRNA Express Endometriosis 2023 12 25
38139296 10.3390/ijmsAssessing theOvarian cance 2023 12 25
38139022 10.3390/ijmsThe Role of CYoung female 2023 12 25
38138904 10.3390/jpm Navigating thOver the last 2023 12 25
38138863 10.3390/jpm Should We AbOvarian cance 2023 12 25
38138636 10.3390/mol Probing AntibUrinary tract 2023 12 25
38138451 10.3390/mol Stereoselecti A series of n 2023 12 25
38138261 10.3390/medManagement<i>Background
of 2023 12 25
38138220 10.3390/medHistopatholog<i>Background 2023 12 25
38138213 10.3390/medThe Manageme <i>Rationale< 2023 12 25
38138162 10.3390/medGramicidin, a<i>Background 2023 12 25
38137949 10.3390/life The Clinical Platelet-rich 2023 12 25
38137377 10.3390/biomTephrosin SupOvarian cance 2023 12 25
38136647 10.3390/bio Selection of Currently, th 2023 12 25
38136595 10.3390/bio Identificatio Ovarian cance 2023 12 25
38136424 10.3390/canc<i>LLGL2</i> Epithelial ov 2023 12 25
38136408 10.3390/cancRelevance of Ovarian sex c 2023 12 25
38136373 10.3390/cancImaging of PePC represents 2023 12 25
38136346 10.3390/cancImproved Pred The importanc 2023 12 25
38136308 10.3390/cancPrevalence ofHereditary Br 2023 12 25
38136291 10.3390/cancAdverse EffecAntibiotic us 2023 12 25
38136272 10.3390/canc"Things Have To report the 2023 12 25
38136266 10.3390/cancAntitumor ActDysregulation 2023 12 25
38136256 10.3390/cancPrognostic FaTo analyze the 2023 12 25
38135438 10.1136/ijgc Low-grade <i>Retrospective 2023 12 22
38135144 10.1016/j.mcEndocrine tum Endocrine cel 2023 12 28
38134754 10.1016/j.yg Preoperative To determine 2023 12 22
38134746 10.1016/j.ej Dual target P Currently ava 2024 1 17
38134066 10.1097/MD.Exploration oThe mortality 2023 12 25
38134056 10.1097/MD.Factors influ Genital cance 2023 12 25
38132997 10.3390/nan Cancer MarkeNanostructure 2023 12 24
38132479 10.3390/cim Clinical Sign The embryonic 2023 12 24
38132461 10.3390/cim Exosomal Carg Ovarian cance 2023 12 24
38132444 10.3390/cim Activation of Recurrence of 2023 12 24
38132382 10.3390/currCombined Inte Combining int 2023 12 25
38132381 10.3390/currLong-Term FolPsammocarcino 2023 12 27
38132375 10.3390/currOvarian CanceEpithelial ov 2023 12 25
38132373 10.3390/currBeyond SterilOvarian cance 2023 12 25
38132318 10.3390/biol Defining the ROvarian cancer 2023 12 24
38131977 10.2196/453 Predicting PoNursing narra 2024 1 5
38131308 10.1016/j.gi Secondary (adThe UK 100,00 2023 12 22
38130863 10.1093/ehjcParaganglioma Reverse takot 2023 12 23
38130428 10.1016/j.mt A follicle-st Late detectio 2023 12 23
38130314 10.21037/tcr New use of prOvarian cance 2023 12 23
38130273 10.1055/s-00Critical Anal Debabrata Bar 2023 12 23
38130134 10.3802/jgo. Supragastric lMetastases in 2023 12 22
38130127 10.1177/030 Diagnostic roTo compare th 2023 12 25
38129848 10.1186/s129Circulating smNo residual d 2023 12 25
38129839 10.1186/s129EpigallocatecGreen tea, a 2023 12 24
38129642 10.1038/s415Comparative O e ncology trea 2023 12 25
38129565 10.1038/s415Comprehensive Lipoyltransfe 2023 12 25
38129495 10.1038/s415Inhibition of Chemoresistan 2023 12 25
38129227 10.1016/j.acrHabitat RadioThis study ai 2023 12 21
38129136 10.1136/ijgc Updated progr In the PAOLA- 2023 12 21
38128630 10.1016/j.cri Efficacy and Ovarian cance 2024 1 6
38128180 10.1016/j.bi Integrated tr Ovarian cance 2024 1 10
38128017 10.1371/jourCorrection: F [This correct 2023 12 23
38127407 10.23736/S27Exploring theGlucagon-like 2023 12 21
38126810 10.1093/procAging hallmarThe ovary is 2023 12 21
38126764 10.1158/2767Phase I studySapanisertib 2023 12 21
38125942 10.3389/foncA tumor cell sExpression of 2023 12 22
38125923 10.1159/000 Endocrine TheAt the end of 2023 12 22
38125920 10.1159/000 Primary PrevePrimary preve 2023 12 22
38125762 10.1002/cai2Clinical charaThe aim of th 2023 12 22
38125729 10.3389/fnutGarlic consump To clarify th 2023 12 22
38125352 10.3892/etm.Research progr The ovary is 2023 12 22
38125108 10.1155/202 Retracted: Cl [This retract 2023 12 22
38124100 10.1186/s132Exploring distThe endometri 2023 12 22
38124008 10.1136/jmg-Recontact to rThe purpose o 2023 12 20
38124001 10.1136/jmg-Risk-reducingIn Japan, the 2023 12 20
38123636 10.1038/s415A neural netwThe current s 2023 12 22
38123510 10.1093/biol Metabolic chaThe relative 2024 1 6
38123321 10.1136/bcr- Rare case of A woman 12 we 2023 12 22
38123227 10.3760/cma.[Etiological a To investiga 2023 12 22
38123199 10.3760/cma.[Study of the <b>Objective 2024 1 2
38123198 10.3760/cma.[Killing effec <b>Objective 2023 12 22
38123189 10.1136/ijgc Non-gestationaChoriocarcino 2023 12 20
38122916 10.1016/j.cri Efficacy and To evaluate t 2023 12 31
38122884 10.1016/j.actSuicide gene Suicide gene 2023 12 23
38118421 10.1016/j.xc GIInger prediHomologous re 2023 12 22
38118413 10.1016/j.xc PRMT blockade Multiple canc 2023 12 22
38116719 10.1080/147 Novel proteom An estimated 2024 1 1
38116560 10.5812/ijpr Co-treatmentNaringenin (N 2023 12 21
38115773 10.4081/reumAnti-N-methylAnti-N-methyl 2023 12 21
38115369 10.1097/MD.Magnetic resoMalignant mix 2023 12 28
38115318 10.1097/MD.Construction High-grade se 2023 12 21
38115303 10.1097/MD.Impact of ovaThis study ai 2023 12 21
38115289 10.1097/MD.MMP-3 gene The re current i 2023 12 29
38115203 10.1111/jog. Increase in c In Japan, Nir 2023 12 20
38115095 10.1186/s400Diagnostic vaThis study ai 2023 12 27
38115068 10.1186/s132Cerebellar met Ovarian cance 2023 12 21
38115063 10.1186/s130Activation of Epithelial ov 2023 12 21
38115041 10.1186/s130Retraction NoNA 2023 12 23
38114788 10.1038/s415MirvetuximabNA 2023 12 19
38114660 10.1038/s415Targeted inhiOlaparib is a 2023 12 21
38114558 10.1038/s415CharacterizatActin beta-li 2023 12 21
38114297 10.1136/bcr- A rare case o Ovarian cysts 2023 12 21
38114269 10.1111/his. Lessons from Currently ava 2023 12 19
38114163 10.1136/ijgc Highlights fr NA 2023 12 19
38113952 10.1016/j.bb Pyroptosis anOvarian cance 2023 12 19
38113873 10.1159/000 3-4 Cycles vs The aim of th 2023 12 19
38113769 10.1016/j.ej Fear of recur Approximately 2023 12 19
38112915 10.1007/s420Contraceptio Ovarian cance 2023 12 19
38112643 10.1158/2767WNT4 Regulate Wnt ligand WN 2024 1 18
38112555 10.1089/jayaDose-Dense Ch <b><i>Purpose 2023 12 19
38112537 10.1080/147 Advancements Ovarian cance 2023 12 25
38112021 10.1002/camBIRC5 facilit Cisplatin-bas 2023 12 19
38111725 10.1097/GOXImmediate Lym Immediate lym 2023 12 20
38111527 10.3389/foncApplication oOvarian cance 2023 12 20
38111255 10.1080/146 Selection of Maintenance t 2024 1 8
38111049 10.1186/s129Revolutionizi Comprehensive 2023 12 20
38110955 10.1186/s129Role of epitheAs aberrant a 2023 12 21
38110823 10.1111/his. Editorial on: NA 2023 12 20
38110532 10.1038/s415Genomic hypom Genomic hypom 2023 12 20
38110296 10.1097/RCT Krukenberg TThe purpose o 2023 12 18
38109991 10.1016/j.mcBone morphoge Ovarian stero 2023 12 21
38109990 10.1016/j.mc&#x3b2;-caten The precise i 2023 12 21
38109851 10.1002/cnr2A potential c Recently, imm 2023 12 18
38109551 10.1073/pna Hyperactive RThe 21kD GTPa 2023 12 20
38109478 10.1093/jjco Interstitial l Drug-induced 2023 12 18
38109371 10.1021/acs. Impact of ColProton magnet 2024 1 8
38109222 10.1089/cbr. Re: "NoncodinNA 2023 12 18
38109210 10.1158/1078Tumor-specifiNCI-MATCH is 2024 1 1
38109103 10.1080/073 Computational Cancer is one 2023 12 18
38107255 10.1021/acspInteractions High-grade se 2023 12 19
38106830 10.18502/ijp Lncrna FGFR3-Ovarian cance 2023 12 19
38106208 10.1101/2023DevelopmentAnoikis
o resis 2023 12 29
38105923 10.26502/jcs Cholesterol BEpithelial Ov 2023 12 19
38105176 10.1186/s130Direct letters The results of 2023 12 19
38104527 10.1016/j.yg Comparison of This multicen 2023 12 17
38104526 10.1016/j.yg ReproductiveMalignant ova 2023 12 17
38103881 10.1016/j.ferThe use of fe To examine wh 2024 1 8
38103761 10.1016/j.cri Adavosertib aWEE1 kinase is 2024 1 8
38103365 10.1016/j.pr P53 and TLR4New prognosti 2023 12 16
38103140 10.1007/s137Effects of Ce Recent anti-c 2023 12 16
38102584 10.1186/s129Integrated bi Polycystic ov 2023 12 18
38102461 10.1038/s414Hsa_circ_0013 Our prelimina 2024 1 17
38101867 10.1136/jitc Correction: CNA 2023 12 21
38101816 10.1136/ijgc MirvetuximabMirvetuximab 2023 12 15
38101815 10.1136/ijgc New horizonsPlatinum-resi 2023 12 20
38101153 10.1016/j.yg What is the moMalnutrition 2023 12 15
38100902 10.1016/j.jin 8-hydroxyquinFourteen nove 2023 12 25
38100640 10.1002/prp2Investigation Cannabinoids 2023 12 18
38100616 10.1002/cncrTop advancesAlthough cure 2023 12 15
38100160 10.1002/ardpPhthalimide-tHumanity is c 2023 12 15
38099993 10.1245/s104Pressurized I We aimed to i 2024 1 5
38099488 10.1093/mutInhibition of Chemoresistan 2023 12 15
38099342 10.3892/mmrTargeted reveThe objective 2023 12 16
38099328 10.1080/147 A review of pEndometriosis 2023 12 28
38098230 10.1016/j.ymBlockade of Macrophages p 2023 12 23
38098223 10.1111/jcm ALKBH5 regula The long nonc 2023 12 15
38097964 10.1186/s128Diagnostic vaTo investigat 2023 12 16
38097766 10.1038/s414Associating CCYP2A6 is a p 2023 12 14
38097740 10.1038/s414Compartment-s Ovarian carci 2023 12 14
38097739 10.1038/s414Discordance bCA-125 alone 2023 12 14
38097686 10.1038/s415Analysis of l Disulfidptosi 2023 12 16
38097346 10.1136/ijgc CardiophrenicEpithelial ov 2023 12 14
38097143 10.1016/j.bb The high-gradHigh-grade se 2024 1 16
38096801 10.1159/000 Significance The aim of th 2023 12 16
38096673 10.1016/j.yg Underrepresen To describe t 2023 12 14
38096561 10.1097/AOGCombined BilaNA 2023 12 16
38096472 10.1200/PO.2Cobimetinib PThe Targeted 2023 12 16
38096044 10.1080/276 Associations Most previous 2023 12 14
38095409 10.26355/eu A risk model Based on the 2023 12 16
38068953 10.3390/ijmsBRACNAC: A <Detecting cop 2023 12 16
38067319 10.3390/cancClonal NeoanClonal mutati 2023 12 9
38063999 10.1007/s106Inherited BRCGenetic susce 2023 12 8
38041901 10.1016/j.yg Pathogenic geTo define mol 2023 12 2
37986706 10.1002/acn3Teratoma path Ovarian terat 2024 1 17
37983855 10.1111/his. Mucinous cystBreast mucino 2024 1 10
37864663 10.1002/jgc4"Out of the bIn the genomi 2023 10 21
37862791 10.1016/j.yg Molecular detThis prespeci 2023 11 20
37789896 10.1177/117 Homologous R Homologous re 2023 10 5
37789421 10.1186/s402Whole-exomeEndometriosis
s 2023 10 5
37762518 10.3390/ijms<i>SYNE1</i><i>SYNE1</i>, 2023 9 29
37732324 10.3389/fgenA novel marker <b>Introducti 2023 9 22
37728427 10.18632/agi<i>NOTCH2</i> The carcinoge 2023 10 12
37628631 10.3390/gen Co-Occurrence Hereditary Br 2023 8 28
37602928 10.1002/ijc.3Randomized, Choosing
t an o 2023 11 27
37592023 10.1038/s415Exome sequenci Linkage and c 2023 9 11
37535879 10.1200/PO.2Biallelic <i> Breast and ov 2023 8 7
37525498 10.1111/jcm ChromosomeEpithelial
ins ov 2023 11 6
37504252 10.3390/cim Whole-ExomeBasal cell ne 2023 7 31
37422528 10.1038/s414Genomic andIn e gastric ca 2023 8 14
37400526 10.1038/s420Genetic charaHigh-grade se 2023 7 5
37335673 10.1097/MD.Pathological Similarities 2023 6 21
37327584 10.1016/j.tr Accurate tumo Homologous re 2023 7 18
37327320 10.1158/1078Identifying MTo evaluate t 2023 9 18
37324278 10.3389/fendOvarian juvenThe aim of th 2023 6 19
37279095 10.1158/1078Adavosertib ECyclin E (CCN 2023 11 2
37207500 10.1016/j.yg Whole exomeLow-grade
s ser 2023 6 27
37185951 10.1002/ijgo Genetic profi To assess the 2023 8 15
37169775 10.1038/s415Distinct hist Low grade ser 2023 5 15
37143137 10.1186/s130Targeting homUterine leiom 2023 5 8
37098771 10.1158/215 Broadening CA retrospecti 2023 6 5
37097678 10.21873/antSomatic Vari Several clini 2023 4 27
37072347 10.1136/jitc BRD4 inhibiti Mismatch repa 2023 4 20
37048111 10.3390/cell Olaparib-Res The PARP inhi 2023 4 14
37024829 10.1186/s128Whole-exomeOvarian
m cance 2023 4 10
37003074 10.1016/j.yg HER2+ endomet HER2 status i 2023 5 19
36969007 10.3389/foncGenetic analyNot all famil 2023 3 28
36943460 10.1007/s002IdentificationImmunotherape 2023 6 15
36862133 10.1158/1078Overcoming Ba To overcome b 2023 7 6
36853301 10.31557/APJPrevalence ofBRCA1 and BRC 2023 3 2
36833203 10.3390/gen Molecular Gen <i>FANCI</i> 2023 3 2
36811844 10.1097/PGPMesonephric Mesonephric
A n 2023 8 15
36762791 10.1111/cas. Spatial genomAlthough the 2023 5 4
36709040 10.1016/j.an Genomic chara Very young pr 2023 4 18
36580137 10.1007/s004The presenceWe found some 2023 6 9
36568162 10.3389/foncImplementatio Translation o 2023 1 3
36531044 10.3389/foncComplex molec Epithelial ov 2022 12 22
36525930 10.1016/j.yg Ovarian and utCarcinosarcom 2023 2 14
36499142 10.3390/ijmsUsing Genomic The preoperat 2023 1 4
36446793 10.1038/s415Pathway-levelBrain metasta 2022 12 1
36427680 10.1016/j.ge IdentificationBreast and ov 2022 12 27
36418296 10.1038/s414Reversion mutThe associati 2022 11 30
36338706 10.3389/foncInherited hetFanconi anemi 2022 11 8
36319158 10.3760/cma.[Human chorio <b>Objective 2022 11 3
36289533 10.1186/s402DUSP5 and PHL Mature cystic 2022 10 28
36270832 10.1016/j.yg Genomic andPatients
e with 2022 12 16
36252998 10.1136/jitc Phase Ib studPreclinical a 2022 10 19
36246633 10.3389/fgenHRD-MILN: Acc Homologous re 2022 10 19
36229265 10.1016/j.yg Genomic profiLow grade ser 2023 10 23
36229065 10.26508/lsa Whole-exomeEpithelial
s ov 2022 10 17
36122798 10.1016/j.an Analysis of r Breast cancer 2022 12 5
36099812 10.1016/j.eb Genetic landsPrimary Ovari 2022 10 18
36089892 10.1111/cge.Fanconi anemi Inherited bia 2022 12 19
36088062 10.1016/j.tjo A case of adulTo illustrate 2022 9 13
36069815 10.1097/PAS Molecular Ana Human papillo 2022 11 15
36038111 10.1016/j.jar Dualistic clas Widespread in 2023 6 5
35970241 10.1053/j.gasClinical and Interval colo 2023 4 1
35965534 10.3389/foncWhole-genome/ The poor prog 2022 8 16
35957765 10.1002/ccr3Dual BRCA1 an Pathogenic va 2022 8 13
35952757 10.1016/j.jb RAD54B mutati Synthetic let 2022 9 29
35913887 10.1158/0008Germline MissCDC20 is a co 2022 10 5
35884425 10.3390/cancUncovering thRare variants 2023 3 8
35701820 10.1186/s130A rare case o Highly differ 2022 6 16
35699480 10.1093/jnci/Genomic DeteLow-stage, lo 2022 11 16
35624308 10.1038/s414A truncating vPrimary ovari 2022 12 22
35599167 10.1016/j.yg Homologous re Carcinosarcom 2022 6 22
35598328 10.1093/bib/Deciphering cMultiple prim 2022 9 26
35565380 10.3390/cancThe Genetic aTo identify c 2023 3 8
35501919 10.1186/s130Impact of neoPatients trea 2022 5 4
35456503 10.3390/gen Case Review: Background: D 2022 4 26
35326647 10.3390/cancMolecular CorThe incidence 2023 5 19
35290602 10.1007/s115A BRCA1 SplicOvarian cance 2022 6 21
35288736 10.1093/hmgWhole-exomePrior s studies 2022 8 24
35201851 10.1200/PO.2<i>PTEN</i> LOvarian cance 2022 4 4
35198414 10.1016/j.cr Investigating Low-grade ser 2022 2 25
35093146 10.1186/s130Neoantigens aDespite the c 2022 3 16
35043201 10.1093/humThe neglecte BReast CAncer 2022 5 4
35038288 10.17305/bjbWhole-exomeOvarian s granu 2022 6 6
35017684 10.1038/s100APOBEC media Endometriosis 2022 5 26
34861889 10.1186/s130A functionall Familial ovar 2022 3 16
34819508 10.1038/s415Geometric netNetwork analy 2021 12 3
34764678 10.2147/IJGMCSMD3 is Asso Globally, ova 2022 4 28
34718237 10.1159/000 Exome-Wide Many Pa cancer t 2022 1 13
34711244 10.1186/s130Massive parallMultiple prim 2021 11 17
34707299 10.1038/s414Meiotic genesPremature ova 2022 4 4
34657565 10.1080/073 Computational Major cause o 2022 12 27
34608183 10.1038/s415NBS1 I171V vaGenetic infor 2021 12 27
34604049 10.3389/foncGenetic VariaSingle nucleo 2022 4 27
34483300 10.1097/PGPMolecular EvaLow-grade, lo 2022 4 22
34456966 10.3389/fgenIdentificatio <i>BRCA1</i> 2021 8 31
34424031 10.2217/imt-Immune cells<b>Aims:</b> 2022 2 1
34380641 10.1158/1078Comparative H A omologous re 2022 4 1
34356119 10.3390/gen Classificatio High-grade se 2022 2 17
34208639 10.3390/diagComparison of Epithelial ov 2021 7 5
34117242 10.1038/s414Analysis of t Yolk sac tumo 2021 6 30
34079052 10.1038/s416Integrated moEndometrioid 2021 6 8
34026625 10.3389/foncExome sequenc Hereditary Br 2021 9 23
34021944 10.1002/oncoHomologous Re Homologous re 2021 9 28
33987408 10.21037/atmThe G199X and The carcinoge 2022 4 23
33934450 10.1111/cas. Clonal evidenMature terato 2021 7 8
33863809 10.1158/1078Safety, Antit The Wee1 kina 2022 3 31
33811746 10.1002/camTumor genomic In high grade 2021 7 20
33803939 10.3390/cancCandidate Mar The benefit o 2023 9 19
33782397 10.1038/s414Germline muta Approximately 2021 4 17
33747898 10.3389/foncDevelopmentHigh o grade se 2022 4 21
33739378 10.1093/biol Whole-exomeMalignant
s ova 2021 12 23
33674143 10.1016/j.yg Molecular chaTo determine 2021 10 7
33557369 10.3390/diseWhole-ExomeMalignant
S tra 2021 3 5
33441310 10.1158/0008Multiomics ChLow-grade ser 2021 8 11
33381450 10.3389/foncIdentificatio The aim of th 2022 4 19
33328126 10.1016/j.yg Re-assigning The developme 2021 6 30
33326660 10.1002/humWhole-exomeThe s current s 2022 3 31
33246418 10.1186/s128An aggressiveAggressive sy 2021 4 27
33240314 10.3389/fgenIdentificatio Deleterious m 2022 4 18
33194730 10.3389/foncMolecular ProGynecologic c 2023 11 4
33123756 10.1007/s002Impact of tumIdentificatio 2021 5 4
33115781 10.1158/1940<i>BRIP1</i>,Familial colo 2022 2 7
33020491 10.1038/s414Molecular strEndometrioid 2020 10 22
33016334 10.1002/pathGenome-wideClinicopathol
m 2021 5 31
33001187 10.1093/clin Identifying OpMicrosatellit 2021 5 24
32923884 10.1200/PO.2<i>BRCA</i> M Homologous DN 2021 6 17
32914019 10.1200/PO.1Endometrial CEndometrial c 2023 8 23
32912664 10.1016/j.yg Biomarkers ofWe sought to 2021 4 9
32901952 10.1002/pathGenomic analy Low-grade ser 2021 5 31
32873813 10.1038/s415Currently fav Tumor heterog 2021 3 8
32845237 10.7554/eLif A missense inPrimary Ovari 2021 3 15
32809180 10.1007/s105Association oRAD51C is kno 2021 6 23
32769429 10.1097/PAS CTNNB1 Mutati CTNNB1 mutati 2021 1 29
32652893 10.1002/mggTwo novel mut Minichromosom 2021 5 27
32650224 10.1016/j.ne Genomic chara Little is kno 2021 7 12
32581083 10.1136/jmedExome and gen Exome and gen 2021 9 2
32575483 10.3390/cell Small Cell C Small cell ca 2021 4 7
32557933 10.1634/theoClinical CharaThere are lim 2021 6 18
32556881 10.1007/s108Novel bialleli Empty follicl 2021 5 27
32473611 10.1111/cas. Clonal lineag Clear cell ca 2020 12 7
32461346 10.1136/jitc Neoantigen loThere is incr 2021 3 17
32444417 10.1158/1078EVOLVE: A Mul PARP inhibito 2021 10 27
32362568 10.1016/j.yg Tumor specifiExtensive gen 2021 2 10
32357859 10.1186/s128Germline whoFamilial case 2021 1 22
32245699 10.1016/j.an Reversion andLittle is kno 2021 1 6
32144347 10.1038/s413Whole transcrDeveloping pr 2020 12 7
32139151 10.1016/j.yg An integratedEndometrioid 2020 10 6
32111026 10.3390/ijmsDisparity bet Inter-patient 2020 12 8
32099096 10.1038/s414Genetic heterHigh-grade se 2020 12 30
32075097 10.3390/cell <i>PIK3R1</i Identifying c 2021 3 9
32054838 10.1038/s414A living biob High-grade se 2020 4 27
31991061 10.1002/camAssociation bDefects in DN 2021 4 23
31936873 10.3390/ht9 Applications Next generati 2020 9 30
31916078 10.1007/s108The second mu It is estimat 2020 12 4
31911616 10.1038/s413Multiregion eImmature tera 2021 7 8
31896750 10.1038/s414Identificatio Sclerosing st 2020 4 13
31883669 10.1016/j.patThe clinicopaOvarian lymph 2020 11 16
31829442 10.1002/pathInterpretatio Pathogenic so 2020 7 7
31681433 10.3389/fgenExome Sequenc Approximately 2021 1 10
31664961 10.1186/s128Metachronous Somatic PTEN 2020 4 6
31577852 10.1002/cjp2Longitudinal Development o 2021 6 22
31573049 10.3892/ijmmThe prospect Ovarian cance 2020 7 27
31562520 10.1093/neu Germline micrThe germline 2021 2 10
31491988 10.3390/gen Focal RecurreHigh grade se 2020 1 16
31464824 10.1097/CMREvaluation ofGermline muta 2020 7 8
31434613 10.1016/j.yg PARP-1 activitCervical canc 2019 11 5
31422574 10.4414/smwPrevalence ofSince the adv 2020 7 29
31341520 10.1186/s130Age-adjusted Genes in the 2022 4 9
31336956 10.3390/ijms<i>BRCA1</i>The aim of th 2019 12 27
31265121 10.1002/ijc.3Whole-exomeDespite
s the i 2020 5 18
31263571 10.1038/s415High frequencGenomic scree 2020 9 30
31221207 10.1186/s404Efficient ide Efficient ide 2020 7 24
31206626 10.1002/cncrPathogenic anBreast cancer 2020 5 18
31078449 10.1016/j.ca FANCM, RAD1, Although 25% 2020 3 6
31056747 10.1002/pathGermline muta Multiple prim 2020 4 13
31012250 10.1111/petrUse of geneticThere is a lim 2020 4 21
31002019 10.1080/153 Pancreatic acAcinar cell c 2020 7 29
30988514 10.1038/s415Detecting theMutations in 2019 6 10
30962002 10.1016/j.pr Integrative i Brain metasta 2020 1 14
30890735 10.1038/s415Burden of uniTumor mutatio 2020 9 24
30866919 10.1186/s129Genetic and eIrregular men 2019 7 8
30858171 10.1136/jmedHomozygosityChromosomal i 2021 6 21
30746283 10.1515/tnscNovel HomozyThe <i>WWOX</ 2020 9 30
30729182 10.1038/s420Somatic mutat Somatic mutat 2020 4 9
30683758 10.1136/ijgc GlucocorticoiHigh glucocor 2021 4 1
30636931 10.1186/s129Markers of ME Although low- 2022 3 31
30630630 10.1016/j.yg PI3K oncogeniAberrant expr 2019 5 13
30584090 10.1073/pna Mutational laOvarian cance 2019 3 12
30560554 10.1002/pathGenomic lands The clonal re 2020 4 6
30428638 10.4143/crt. Genetic Profi Recurrence an 2019 12 17
30428062 10.1093/humIatrogenic enDoes incision 2019 8 13
30415991 10.1016/j.yg Analysis of mMutational si 2019 2 4
35135122 10.1200/PO.1<i>BRAF</i> M Low-grade ser 2022 2 9
30338611 10.1002/gcc. Novel MXD4-NU Primary ovari 2018 12 11
30284660 10.1007/s106Ovarian smallOne of a pair 2019 8 26
30170975 10.1016/j.yg The genetic l Ovarian germ 2018 11 9
30166312 10.1158/154 Mutational L Adult granulo 2020 1 23
30128536 10.1001/jamaAssociation oSince the dis 2019 12 19
30078747 10.1016/j.cceComprehensive Our comprehen 2019 6 10
30075111 10.1016/j.ajhBi-allelic Re Infertility a 2019 5 13
30028354 10.1097/PGPNext-generatiOvarian spind 2020 1 27
30021104 Novel targeteCarcinosarcom 2018 11 5
29986747 10.1186/s130EstablishmentOvarian clear 2018 11 26
29950560 10.1038/s414KMT2D/MLL2Adult-type
in gr 2019 1 11
29892687 10.1016/j.go Clonal lineag Neurofibromat 2020 9 30
29853601 10.1158/1078T-cell Respon<b>Purpose:</ 2019 11 18
29793804 10.1016/j.yg Massively parMucinous ovar 2018 8 6
29604063 10.1002/pathSomatic POLEGenomic insta 2019 10 22
29498984 10.1097/IGC Combination Tohe purpose o 2019 4 15
29464067 10.18632/oncGene aberratiThere has bee 2019 11 20
29425284 10.1093/humChromosomalWhat i is the p 2019 1 21
29351920 10.1158/1078Exceptional R<b>Purpose:</ 2019 12 20
29331980 10.1136/jmed<i>DMC1</i> The m genetic c 2019 9 20
29267927 10.1093/gigaVaDiR: an int Advances in n 2018 11 19
29261187 10.1038/gim.Early cancer PurposeThe cl 2018 9 26
29233531 10.1016/j.yg Genomic lands To analyze wh 2018 7 2
29162652 10.1101/mcs Elucidating Synchronous e 2018 1 1
29061967 10.1038/s414High grade seHigh-grade se 2018 4 17
29056561 10.1016/j.ej Bloom syndrom Bloom syndrom 2018 8 14
28972072 10.1158/0008Clonality, He Synchronous b 2018 1 5
28940304 10.1002/cncrThe FOXA2 traUterine carci 2017 12 26
28888422 10.1016/j.ajpExome Sequenc Previous stud 2017 10 4
28881617 10.18632/oncGermline whol We analyzed w 2017 9 25
28775167 10.1158/0008IdentificationIt has been e 2017 10 27
28759038 10.1038/onc.High-depth, hiThere remains 2017 12 1
28748527 10.1002/ijc.3The prevalencThe DICER1 sy 2017 10 27
28646021 10.1158/0008<i>EIF1AX</i>Low-grade ser 2017 9 29
28608987 10.1002/pathSMARCA4 inact SMARCA4 chrom 2017 9 26
28606096 10.1186/s128Pan-cancer ana Cancer resear 2018 2 19
28591191 10.1371/jourReanalysis of While up to 2 2017 9 18
28541631 10.3802/jgo. Germline andTo define gen 2018 1 4
28301456 10.1038/gim.Prediction of Identifying w 2018 5 4
27913932 10.1007/s105Almost 2% of There is stil 2017 12 7
27896549 10.1007/s106Embryonal rha Germline muta 2018 2 9
27856443 10.1158/2159Genomics of O Accumulating 2017 10 26
27844240 10.1007/s106Identificatio Nijmegen brea 2018 2 9
27791010 10.1073/pna Mutational laCarcinosarcom 2018 2 7
27491810 10.1038/modp Molecular genUndifferentia 2018 1 11
27782108 10.1038/ejhgWhole-exomeAsremarkable 2017 7 26
27741368 10.1002/pathIntraindividuaIntraindividu 2017 5 9
27573169 10.1158/1078Establishment<b>Purpose:</ 2018 2 9
27530326 10.1158/0008CRISPR/Cas9-There is a ne 2017 8 7
27471560 10.7150/jca. Genomic/Epige Ovarian carci 2016 7 29
27454254 10.1186/s128Abstracts fro O1 Regulation of genes by telomere length over long distances Jerry W. Sha
38241559 10.1097/MD.Phenotypes ofHereditary se 2024 1 19
38241155 10.1016/j.ne A clinical ap This paper pr 2024 1 19
38239845 10.7759/cureA Case of a Nemaline myop 2024 1 19
38239591 10.3389/fpedCase Report: Persistent pu 2024 1 19
38238844 10.1186/s129Identificatio Antenatal Bar 2024 1 18
38238738 10.1186/s129EstablishmentAlthough meni 2024 1 18
38238519 10.1038/s415The expanding Genomic techn 2024 1 18
38237273 10.1016/j.le The grading dThe diagnosis 2024 1 18
38236904 10.1371/jourKuura-An autThe advent of 2024 1 18
38236768 10.1016/j.xp Protocol for NA 2024 1 18
38236436 10.1007/s110Novel LDLR vaFamilial hype 2024 1 19
38235704 10.1097/WCORecent advanc Genetics stud 2024 1 18
38235691 10.1177/153 InflammationChagas diseas 2024 1 19
38235364 10.1212/NXGBiallelic <i> The human gen 2024 1 19
38235353 10.2174/011 Identificatio Currently, pr 2024 1 19
38235041 10.1212/NXGPMPCA-RelateThe <i>PMPCA< 2024 1 19
38235039 10.1212/NXG<i>IRF2BPL</iNeurodevelopm 2024 1 19
38234783 10.1101/2023Germline andMutations are 2024 1 18
38234180 10.1002/ajmgComplex balan Axenfeld-Rieg 2024 1 18
38233949 10.1186/s410A novel misseFibrinogen pl 2024 1 19
38233937 10.1111/nep.Interpreting We describe a 2024 1 17
38233770 10.1186/s128Expanding theSCN8A-related 2024 1 19
38231342 10.1007/s441Familial Scre Lipodystrophy 2024 1 17
38230957 10.4274/jcrp Floating-HarbFloating-Harb 2024 1 17
38230350 10.1016/j.gi Biallelic var The aim of th 2024 1 18
38229971 10.1055/s-00Identificati <b>Background 2024 1 18
38229970 10.1055/s-00Novel Variant<b>Introducti 2024 1 18
38229969 10.1055/s-00A Pair of Com<b>Background 2024 1 18
38229655 10.4103/aianClinical and Monomelic Amy 2024 1 18
38229652 10.4103/aianMitochondrialMitochondrial 2024 1 18
38228874 10.1038/s100Novel compoun The gene for 2024 1 16
38228861 10.1111/andrNovel variatioTeratozoosper 2024 1 16
38228392 10.1136/jmg-<i>GRN</i> mMETHODS: The 2024 1 16
38228391 10.1136/jmg-Whole-exome<b>Background
s 2024 1 16
38228144 10.1016/j.ajhSTIGMA: Single Clinical exom 2024 1 16
38226287 10.1016/j.he Neurofibromat Neurofibromat 2024 1 17
38226203 10.1016/j.ymA synonymous Maturity-onse 2024 1 17
38225558 10.1186/s128A novel de noWe aimed to e 2024 1 17
38225536 10.1111/cge.Functional chCongenital hy 2024 1 15
38224959 10.1055/a-22Digenic InherVenous thromb 2024 1 15
38224868 10.1016/j.ot Genetic diagnCongenital/ea 2024 1 18
38223339 10.1093/ckj/ Single-cell t Denys-Drash s 2024 1 16
38223133 10.1016/j.waClinical varia Perioperative 2024 1 16
38222807 10.1002/jsp2A missense <iThis study ai 2024 1 16
38222456 Identificatio To evaluate t 2024 1 16
38221827 10.1111/cge.The clinical Developmental 2024 1 15
38221731 10.1111/andrAn integratedNon-obstructi 2024 1 15
38221620 10.1186/s130Clinical, bio Multiple acyl 2024 1 16
38220134 10.1016/j.cc Molecular diaSignificant d 2024 1 18
38219857 10.1016/j.oreSpectrum of gInherited ret 2024 1 14
38219528 10.1016/j.parClinical and gThe genetics 2024 1 14
38219345 10.1016/j.ps Did the human The Human Gen 2024 1 14
38219146 10.1016/j.ce DNA polymeras Alterations i 2024 1 14
38218042 10.1016/j.pr Loss of helic Schimke immun 2024 1 13
38217005 10.1186/s130Genomic andNeoadjuvant
t c 2024 1 15
38216990 10.1186/s129Comprehensive Cornelia de L 2024 1 15
38216553 10.1038/s414Single-cell m Vestibular sc 2024 1 15
38215673 10.1016/j.jss Identificatio Ventricular s 2024 1 12
38215144 10.1097/MD.A de novo varAutosomal dom 2024 1 15
38214746 10.1007/s003An unusual prPathogenic va 2024 1 12
38213835 10.1093/noajA LINE-1 mediRetinoblastom 2024 1 13
38213817 10.21037/atmMorbidity andNA 2024 1 13
38213489 10.1093/ckj/ Mechanisms of Branchiootore 2024 1 13
38213329 10.3389/fim Antigen preseThe GL261 and 2024 1 15
38212584 10.1007/s430Splicing MutaOligo-astheno 2024 1 11
38206414 10.1007/s004Macular dystrKabuki Syndro 2024 1 11
38205742 10.1016/j.gi Real-world diTo determine 2024 1 11
38205536 10.3324/haem Evaluation of Genetic predi 2024 1 11
38205005 10.1016/j.jacGene-Level AAnthracycline 2024 1 15
38204320 10.24953/turA novel homoz Benign recurr 2024 1 12
38204317 10.24953/turNovel sphingoSphingosine p 2024 1 12
38203665 10.3390/ijmsTriple GeneticWe describe t 2024 1 12
38203287 10.3390/ijms<i>PSEN1</i>A pathogenic 2024 1 12
38202188 10.3390/jcm Prenatal ExomTo evaluate t 2024 1 12
38202130 10.3390/jcm An Update onImmunoglobuli 2024 1 12
38201285 10.3390/cell CharacterizatSinonasal ter 2024 1 12
38200129 10.1038/s415Public platfo Acquiring a s 2024 1 10
38200082 10.1038/s414Confirmation Numerous cont 2024 1 16
38199770 10.3760/cma.[Clinical path <b>Objective 2024 1 12
38199610 10.1136/jitc Multiomics prAs an unconve 2024 1 12
38197923 10.1007/s004Technical str Monozygotic ( 2024 1 10
38197863 10.1182/blooRisk Factors Clonal hemato 2024 1 10
38197720 10.1002/jgc4DevelopmentOver o the past 2024 1 10
38197452 10.1080/160 Insights into This study ai 2024 1 11
38197426 10.1080/138 Frail inner l We report a t 2024 1 10
38195207 10.1101/gr.2 A Bayesian fr Genetic and g 2024 1 9
38194456 10.1073/pna A structurall De novo heter 2024 1 11
38193396 10.1016/j.gi Unbiased phen Widespread ap 2024 1 9
38192884 10.4103/abr. A Homozygous Recessive dis 2024 1 10
38192829 10.1016/j.he Brachyolmia, Brachyolmia i 2024 1 10
38192810 10.1016/j.he Novel presentAromatic l-am 2024 1 10
38192426 10.3389/fendThe first exomType 2 diabet 2024 1 10
38192425 10.3389/fendA novel <i>PHGlycogen stor 2024 1 10
38192023 10.1002/prosWhole-exomeThrough
s whole 2024 1 9
38192009 10.1002/ajmgAn unusual diAlpha-mannosi 2024 1 9
38191074 10.1016/j.jaaEfficiency of NA 2024 1 8
38189198 10.1002/ajmgThe first Tur ABH8, the pro 2024 1 8
38189110 10.1002/ijgo Prenatal diagDuplex kidney 2024 1 8
38188848 10.1002/ccr3IdentificationFazio-Londe d 2024 1 9
38187265 10.1016/j.he CharacterizatCongenital he 2024 1 9
38186994 Clinical appl To apply whol 2024 1 9
38186890 10.1093/ckj/ Replacing a kNA 2024 1 9
38186885 10.1093/ckj/ Beyond the kiAccording to 2024 1 9
38186093 10.3760/cma.[Analysis of <b>Objective 2024 1 12
38185793 10.1111/os.1Pay AttentionFibrodysplasi 2024 1 7
38185613 10.1016/j.patCurrent updatSoft tissue s 2024 1 7
38185557 10.1016/j.asj Evaluation of Immunohistoch 2024 1 7
38184822 10.1080/216 EstablishmentThe prevalenc 2024 1 9
38184690 10.1038/s414PIEZO1 loss-oPrune belly s 2024 1 8
38184646 10.1186/s130Combining a p5' untranslat 2024 1 8
38184101 10.1016/j.ajoEarly DiagnosTo explore th 2024 1 6
38182823 10.1038/s413Germline muta Childhood can 2024 1 5
38182156 Coffin-Siris Coffin-Siris 2024 1 8
38181929 10.1016/j.ge Comorbidity oElevated rate 2024 1 17
38181896 10.1016/j.jggRCAN family m Noncompaction 2024 1 5
38181819 10.1055/a-22Early-onset dThe associati 2024 1 18
38181735 10.1016/j.ajhA syndromic nPPFIA3 encode 2024 1 8
38181165 10.2106/JBJSPerthes-Like Bohring-Opitz 2024 1 8
38180615 10.1007/s120Clinical Char Microcephaly 2024 1 5
38180561 10.1007/s004Genomic analy Perinatal str 2024 1 19
38180355 10.1002/pd.6The genetic etThe goal of t 2024 1 5
38180342 10.1002/pathMutational siAdenocarcinom 2024 1 5
38179855 10.1002/ajmgc.202_204delNucleoporins 2024 1 5
38179413 10.1212/NXGNovel In-FramIntellectual 2024 1 6
38179410 10.3389/fgenIdentificatio <b>Background 2024 1 6
38179148 10.1159/000 Two JapaneseHexokinase 1 2024 1 6
38178812 10.1016/j.ymClinical and Heme oxygenas 2024 1 6
38178268 10.1186/s130Using multi-s Next-generati 2024 1 8
38178226 10.1186/s130Contribution o The contribut 2024 1 8
38177974 10.1007/s108Pathogenic miWomen undergo 2024 1 4
38177695 10.1038/s415Exome sequenc Sleep is vita 2024 1 4
38177409 10.1038/s414Decoding comp Rare diseases 2024 1 4
38177406 10.1038/s414DAG1 haploins DAG1 encodes 2024 1 4
38177227 10.1038/s415The contributPolymyalgia r 2024 1 8
38175965 10.1212/WNLVideo AnalyseMore than 2,9 2024 1 8
38175856 10.1212/WNLTeaching NeurA 48-year-old 2024 1 8
38175776 10.1093/bioi HAT: de novode novo varia 2024 1 11
38175593 10.1093/clin The Pivotal R NA 2024 1 5
38175432 10.1007/s123Indolent B-ceT(14;19) is a 2024 1 5
38175272 10.1007/s110A novel homoz Both non-obst 2024 1 5
38175148 10.5603/pjnnGenetics of PaAdvances in s 2024 1 4
38174605 10.3322/caacInterpreting aThe last deca 2024 1 4
38174045 10.3389/fgenImportance ofVascular Ehle 2024 1 5
38173802 10.1093/bra Expanding theMutations in 2024 1 5
38173481 10.1016/j.he Harel-Yoon syTo describe t 2024 1 5
38173341 10.1210/clin A mosaic variOsteopathia s 2024 1 4
38173219 10.1111/cge.CCDC88C varia CCDC88C gene, 2024 1 4
38173046 10.1186/s402The diversity Clopidogrel i 2024 1 5
38172590 10.1038/s415Whole transcrThis study ai 2024 1 5
38172272 10.1038/s415Genetic ancesIt has been s 2024 1 6
38171566 10.3760/cma.[Clinical phenTo explore th 2024 1 5
38171565 10.3760/cma.[Analysis of To explore th 2024 1 5
38171564 10.3760/cma.[Clinical cha To explore th 2024 1 10
38171563 10.3760/cma.[Analysis of To analyze th 2024 1 10
38171562 10.3760/cma.[Genetic analTo explore th 2024 1 10
38171555 10.3760/cma.[Correlation To explore th 2024 1 10
38170232 10.1007/s004Predicting theVariants whic 2024 1 12
38170106 10.3389/fme The most comm Genetic focal 2024 1 5
38168905 10.1002/advsOR11H1 Missen Vogt-Koyanagi 2024 1 3
38168645 10.1038/s420Recessive TMFamilial card 2024 1 5
38168635 10.1038/s415Contribution Fetal growth 2024 1 5
38168579 10.1016/j.ped"Hole" ExomeWhole exome s 2024 1 3
38168508 10.1002/acn3Clinical utili Evaluation of 2024 1 3
38168433 10.21203/rs. 5-Aza-4'-thio DNA methyltra 2024 1 10
38168423 10.1101/2023STAT4 Phospho Chronic rhino 2024 1 8
38168307 10.1101/2023Exome-wide ta The human sub 2024 1 3
38167959 10.1038/s415CharacterizatiDrug insensiti 2024 1 5
38167765 10.1093/jalmInterrogatingPharmacogenet 2024 1 5
38167599 10.1038/s415Whole&#x2011; Lewis lung ca 2024 1 5
38167455 10.1038/s415Identificatio Diagnosing lo 2024 1 5
38167265 10.1017/S10 Myxomatous Myxomatous
de de 2024 1 3
38167256 10.1038/s414ECOLE: LearniCopy number v 2024 1 5
38167091 10.1186/s129Carrier frequ People with a 2024 1 5
38166944 10.1186/s130A novel misseTrp3 allele i 2024 1 17
38166771 10.1186/s128Association bPolycystic ov 2024 1 17
38166572 10.1186/s128A novel pathoPrimary carni 2024 1 4
38166029 10.1371/jourComprehensive Glioblastoma 2024 1 4
38163890 10.1186/s130RPTOR blockad Ceramide meta 2024 1 3
38165124 10.1002/pd.6Prenatal diagTo describe t 2024 1 2
38164991 10.1002/jum.Prenatal DiagTo prospectiv 2024 1 2
38164890 10.1016/j.gi The cost of p Rare disease 2024 1 2
38164622 10.1002/ajmgFragile X syndThe FMR1 5' r 2024 1 2
38164514 10.3389/fgenWhole exomeLeft s ventricu 2024 1 3
38164512 10.3389/fgenCase report: <b>Introducti 2024 1 3
38163449 10.1016/j.bb Genetic varianCerebral pals 2024 1 3
38163266 10.1002/pd.6Raine syndrom Raine syndrom 2024 1 1
38163131 10.1016/j.he Compound hete The <i>WDR19< 2024 1 3
38163100 10.1016/j.he HeterozygousTo identify c 2024 1 3
38162681 10.3389/fgenWhole-exome<b>Introducti
s 2024 1 3
38161285 10.1002/pd.6Novel compoun A couple was 2024 1 1
38161202 10.1007/s406The risk of coSummarize and 2023 12 31
38160741 10.1016/j.ge Clinical and The VPS13 fam 2024 1 10
38160484 10.1016/j.pr ClinicopatholPlasmablastic 2023 12 31
38160027 10.1136/bcr- Thurston syndA male infant 2024 1 17
38159268 10.1002/pd.6Successful anA new form of 2023 12 30
38159148 10.1007/s100Novel ERLIN2The Brazilian 2023 12 30
38158857 10.1016/j.gi Differential a Oral-facial-d 2023 12 30
38158856 10.1016/j.gi Biallelic los We establishe 2023 12 30
38158591 10.1002/pd.6Trust in pren Despite exome 2023 12 29
38158391 10.1002/ajmgHigh number Advances
o in b 2023 12 29
38158197 10.1055/s-00Gaining Insig &#x2003;Inves 2023 12 29
38157055 10.1007/s007Identificatio This study ai 2024 1 3
38156946 10.1002/mggNovel homozyMeckel syndro 2023 12 29
38156126 10.7759/cureA Diagnostic CCongenital pso 2023 12 30
38155715 10.3389/fgenIncorporatingExome sequenc 2023 12 30
38156365 10.1002/ajmgRASopathies aRASopathies a 2023 12 29
38154976 10.3760/cma.[Zellweger sy<b>Objective 2024 1 1
38154558 10.1016/j.kinImplication o Congenital an 2024 1 8
38154517 10.1016/j.pn IdentificationRare variants 2024 1 15
38154480 10.3349/ymj.Diagnosis of To assess the 2024 1 1
38154379 10.1016/j.eb Bi-allelic var Pathogenic va 2024 1 18
38153748 10.1167/iovs.Double Hypera Variants in C 2024 1 6
38153683 10.1007/s120The DiagnostiSeveral neuro 2023 12 28
38153581 10.1007/s110Identificatio Metachromatic 2023 12 29
38153174 10.1093/nar/HMZDupFinder: Homozygous du 2024 1 10
38153133 10.1002/ajmgA novel singl Congenital ca 2023 12 28
38152862 10.1093/mol The Impact ofThe strategic 2024 1 15
38152650 10.3389/fpedPrimary bilia Primary bilia 2023 12 29
38152600 10.5049/EBP.Pseudo-Gitelm Pseudo-Bartte 2023 12 29
38152138 10.3389/fendIdentificationVery tall peo 2023 12 29
38152133 10.3389/fendAn aggressiveGermline succ 2023 12 29
38151328 10.3779/j.iss [Mutational SIn China, lu 2024 1 3
38151071 10.1016/j.cc Liquid biopsy Liquid biopsy 2024 1 10
38150042 10.1007/s105Discovery andIntracranial 2024 1 11
38149472 10.1242/dev.A lissencephaLissencephaly 2024 1 19
38149346 10.1002/ajmgLate-onset muMucopolysacch 2023 12 27
38149330 10.1111/petrSCYL1 deficienPediatric acu 2023 12 27
38149253 10.3389/fim Utilizing immAdvancements 2023 12 28
38149215 10.1016/j.ymA <i>de novo<Non-immune hy 2023 12 28
38149096 10.3389/fendSingle-cell RNThe number of 2023 12 28
38149039 10.1212/NXG<i>C9orf72</iA hexanucleot 2023 12 28
38148910 10.3389/fme Case report: Hereditary el 2023 12 28
38148819 10.1016/j.he Digenic <i>CHCHARGE syndro 2023 12 28
38148624 10.1111/cge.Identifying c An estimated 2023 12 27
38148610 10.1002/mdsGain-of-FunctKinase D-inte 2023 12 27
38148580 10.1002/acn3Dystonia, spaMovement diso 2023 12 27
38148155 10.1111/cge.A bi-allelic Nonobstructiv 2023 12 26
38148081 10.21873/invSpectrum of PX-linked hypo 2024 1 4
38148006 10.1002/pd.6Biallelic trun To report two 2023 12 26
38147818 10.4143/crt. Invasiveness oIn this study 2023 12 26
38146907 10.1002/mggA novel 11 baHaploinsuffic 2024 1 8
38146894 10.1002/mggNovel mutatioNorrie diseas 2024 1 8
38146529 10.2147/TAC A New InheritSudden cardia 2023 12 27
38146137 10.1002/mggThe c.386A&gt Juvenile Poly 2024 1 8
38146112 10.1111/pai. Whole-exomeWhole-exome
s s 2023 12 27
38145795 10.1016/j.ex TYR mutationOculocutaneou 2023 12 29
38145611 10.1016/j.parUnraveling thHereditary at 2023 12 25
38143235 10.1002/cac2Multiomics anIntrahepatic 2023 12 24
38143038 10.1016/j.kinIdiopathic co Collapsing gl 2024 1 15
38143025 10.1016/j.ej Fetal hepatic Arboleda-Tham 2023 12 27
38142265 10.1038/s414Cancer predi Wilms tumor ( 2023 12 23
38141912 10.1016/j.bi Uncommon prot Suicide is a 2023 12 23
38141656 10.1177/030 Identificatio Herein, we re 2024 1 10
38141485 10.1016/j.ejoIsolated poly To analyze th 2023 12 23
38141254 10.1093/neu Whole tumorThe a TERT prom 2023 12 23
38139322 10.3390/ijmsPhenotype-Gen This study hi 2023 12 25
38138952 10.3390/jpm Prevalent VarFamilial hype 2023 12 25
38137006 10.3390/gen HeterozygousBreast cancer 2023 12 25
38136988 10.3390/gen Evaluation ofFacioscapuloh 2023 12 25
38136979 10.3390/gen Duplication aChromosomal s 2023 12 25
38136976 10.3390/gen A Case ReportMitochondrial 2023 12 25
38136965 10.3390/gen NUP85 as a NPathogenic ge 2024 1 9
38135866 10.1007/s120Association BThe dispropor 2024 1 1
38135704 10.1038/s415Application oGliomas with 2023 12 25
38135698 10.1038/s414STAT5a and SH Primary myelo 2023 12 22
38135440 10.1002/ajmgA case of MB MBTPS1 (NM_00 2023 12 22
38135117 10.1016/j.lfs Advancements Triple-Negati 2024 1 8
38134749 10.1016/j.co An integrativ Non-silent si 2023 12 22
38134649 10.1016/j.sei Clinical phenoSeizure thres 2023 12 22
38134094 10.1097/MD.Retinitis pig Retinitis pig 2023 12 25
38133768 10.1007/s430Etiology and Cerebral pals 2023 12 22
38132465 10.3390/cim A Novel MutatAutosomal rec 2023 12 24
38132285 10.3390/biol The DiagnostiNeurogenetic 2023 12 24
38132069 10.3390/healA Panel-AgnosGenome sequen 2024 1 1
38131811 10.3390/audiWhich Came FUsher syndrom 2023 12 24
38130902 10.1093/noajPatient-deriv Treatment res 2023 12 23
38130779 10.12998/wjcPulmonary fun Methylmalonic 2023 12 23
38130541 10.7759/cureSiblings With Immune thromb 2023 12 23
38129817 10.1186/s129Novel pathoge Dilated cardi 2023 12 25
38129747 10.1111/odi. Identificatio To investigat 2023 12 22
38129739 10.1007/s108Fatal COVID-1While SARS-Co 2024 1 3
38129582 10.1038/s415Combining chrDespite the c 2023 12 25
38129378 10.1038/s413A novel autis The landscape 2024 1 3
38129218 10.1016/j.br A comprehensi Mitochondrial 2023 12 21
38129107 10.1093/hmgLoss of NDST1Intellectual 2023 12 21
38128548 10.1093/brai A novel SMARC Hydrocephalus 2024 1 1
38127226 10.1007/s121Congenital dyCongenital dy 2023 12 21
38127101 10.1007/s004Next-generatiNeuromuscular 2023 12 21
38126872 10.7554/eLif IdentificationMale infertil 2023 12 27
38125836 10.3389/fneuProspective eEpilepsy is o 2023 12 22
38125821 10.3389/fpedCase Report: Aminoacyl-tRN 2023 12 22
38125752 10.3389/fgenCase report: Brody Disease 2023 12 22
38125503 10.1016/j.he CHD2 pathogen Chromosomal i 2023 12 22
38124431 10.1002/mdsClinicogeneti NA 2023 12 21
38123995 10.1136/jmg-Clinical phen The first stu 2023 12 20
38123822 10.1038/s414Deciphering tThe COVID-19 2023 12 20
38123482 10.1136/rmd<i>NLRP12</i> <i>NLRP12</i> 2023 12 22
38118446 10.1016/j.ajhBi-allelic ge The homologou 2024 1 8
38117803 10.1371/jourImage-localizBrain cancers 2023 12 22
38117582 10.1097/IAE HIGH MYOPIAHigh myopia c 2023 12 22
38117494 10.1001/jam Association oPIK3CA mutati 2023 12 22
38117436 10.1007/s132Clinical repo Neurodevelopm 2023 12 20
38117287 10.1097/PAS Melanotic PECPerivascular 2023 12 21
38116750 10.1002/ajmgA severe neurCHD3 heterozy 2023 12 20
38116463 10.2147/IMCRA Rare Case RA newborn wit 2023 12 21
38115997 10.3389/fim Case Report: ISG15 deficie 2023 12 21
38115798 10.1111/bjh. Germline gene Multiple myel 2023 12 20
38115267 10.1097/MD.Neonatal KabKabuki syndro 2023 12 21
38114997 10.1186/s129Novel compoun Cystinuria is 2023 12 29
38114870 10.1007/s108An overview oThe cystic fi 2023 12 20
38114583 10.1038/s414De novo variaThe contribut 2023 12 19
38113653 10.1016/j.lu Comparison of Lung cancer i 2024 1 8
38113582 10.1016/j.ejoPrenatal evaluTo comprehens 2023 12 19
38113391 10.1093/lab Whole-exomeThoracic
s aort 2023 12 19
38112783 10.1007/s004Genetics scree Amyotrophic L 2023 12 19
38111983 10.1002/camA recurrence-Although adju 2023 12 19
38111981 10.1002/mggNovel compoun Fructose-1,6- 2024 1 8
38111930 10.18240/ijo.A pedigree wiTo characteri 2023 12 20
38111929 10.18240/ijo.<i>De novel</To investigat 2023 12 20
38111628 10.3389/fpedKnowledge map The etiology 2023 12 20
38111203 10.1002/pd.6Biallellic var Fetal arthrog 2023 12 25
38111042 10.1186/s129A novel de noAbout 31 indi 2023 12 20
38110882 10.1186/s128The first Chi Hemoglobin (H 2023 12 20
38110397 10.1038/s414Genetic and eDeveloping sy 2023 12 20
38110236 10.1002/pd.6A novel NONOAt 16&#xa0;+& 2023 12 18
38110044 10.1016/j.ge Exome sequenc High myopia ( 2024 1 17
38110042 10.1016/j.ge Identificatio Verheij syndr 2024 1 17
38109455 10.2478/priloCompound Hete Cerebellar at 2023 12 20
38108099 10.1111/cge.RUNX2-related Metaphyseal d 2023 12 18
38107744 10.1177/232 Surgical ReseWe describe a 2023 12 19
38107089 10.21037/apcDirect identifPrediction of 2023 12 19
38105698 10.3724/zdxbGenetic analyA 13-year an 2024 1 5
38105692 10.3724/zdxb<i>ATAD3A</i> An 11-day-ol 2024 1 5
38105687 10.3724/zdxbAutosomal dom To analyze t 2024 1 5
38105315 10.1007/s100Atypical retinTypical retin 2023 12 17
38104891 10.1016/j.moMolecular ChaTFE3-rearrang 2024 1 17
38103592 10.1016/j.jm Slice Testing As the number 2023 12 30
38102777 10.1002/ajmgExploring the The increased 2023 12 16
38102591 10.1186/s128A comprehensRNA-Seq analy 2023 12 18
38102329 10.1038/s414Genetic basisOsteogenesis i 2023 12 15
38102195 10.1038/s100RNA sequencin More than hal 2023 12 15
38101565 10.1016/j.ej LRP4 site-speLRP4 is expre 2023 12 20
38100419 10.1073/pna A role for muIdiopathic no 2023 12 18
38100037 10.1007/s108A Novel Biall Lymphocyte-sp 2023 12 20
38099988 10.1007/s108Human Autoso The DNA polym 2023 12 16
38099339 10.3892/mmrA frameshift Liddle syndro 2023 12 16
38099231 10.3389/fcvmCardioneuroab Cardioneuroab 2023 12 16
38098475 10.3389/fgenProminent mus Isolated mito 2023 12 16
38098088 10.1186/s130Prevalence ofThe homologou 2023 12 16
38098057 10.1186/s130Beyond the exLong-read who 2023 12 16
38098042 10.1186/s129An FGFR2 muta Osteoporosis 2023 12 16
38097983 10.1186/s128Two novel mut Bifid nose is 2023 12 20
38097767 10.1038/s414Exome sequenc Alternating h 2023 12 14
38097387 10.1111/cch.Parents' viewsIndividuals wi 2024 1 6
38096369 10.1182/blooLow-frequency Extreme disea 2023 12 14
38096238 10.1371/jourExome sequenc Pituitary sta 2023 12 16
38095907 10.1167/iovs.EstablishmentEyelid sebace 2023 12 16
38094283 10.30476/IJMA Novel Arg12As the most c 2023 12 16
38093606 10.1002/mggGermline muta Childhood can 2024 1 8
38093364 10.1186/s130Comprehensive In China, ~1, 2023 12 16
38092052 10.1093/bioi BenchmarkingThe steady in 2023 12 25
38091987 10.1016/j.ajhSystematic anProtein-trunc 2024 1 8
38091967 10.1159/000 Phenotypic anTo investigat 2023 12 13
38091959 10.1159/000 Novel variantHermansky-Pud 2023 12 13
38091257 10.1002/pd.6Prenatal diagAutosomal rec 2023 12 13
38089969 10.3389/fnin Freezing of gaMutations in 2023 12 13
38089682 10.3389/fpedCase Report: Dilated cardi 2023 12 13
38089646 10.3389/poreCase report: Squamous diff 2023 12 16
38089638 10.1093/noajThe Neurogeno Glioblastoma 2023 12 13
38088752 10.4274/jcrp Clinical Pres In terms of p 2023 12 13
38088234 10.1111/cge.Exome sequenc Intellectual 2023 12 13
38088023 10.1111/epi. Dissecting ge Epilepsy with 2023 12 23
38087948 10.1002/mggBiallelic pat Biallelic pat 2024 1 8
38087879 10.1002/gcc. The impact ofA common find 2024 1 4
38087819 10.1002/mggNovel de novoPrimrose synd 2024 1 8
38086165 10.1016/j.yg Genomic chara The greatest 2023 12 12
38085046 10.1200/GO. Understanding The purpose o 2023 12 16
38084697 10.7754/Clin A Case of Fet Familial hemo 2023 12 16
38084506 10.1515/jpemHereditary h Hereditary hy 2023 12 12
38083999 10.1002/jcb. Novel mutatioPrimary open- 2024 1 16
38083992 10.1111/cas. PostoperativeBiomarkers th 2023 12 12
38083972 10.1002/mggAutosomal recIntellectual 2024 1 8
38082334 10.1002/ajmgDe novo variaBladder exstr 2023 12 12
38082310 10.1186/s129A novel 268&# Severe combin 2023 12 16
38081329 10.1016/j.op Bony Congenit Aplasia of la 2023 12 11
38079070 10.1007/s120ASAH1&#xa0;V Spinal muscul 2023 12 11
38078932 10.1007/s002Identificatio Familial hypo 2023 12 11
38077957 10.1016/j.ymExpanding th Polyglucosan 2023 12 11
38077838 10.29399/npac.4168G&gt;A( Schizophrenia 2023 12 11
38077157 10.3748/wjg.First report Extrahepatic 2023 12 16
38076942 10.1101/2023SJPedPanel: AExtensive eff 2023 12 11
38076939 10.1101/2023AutoGVP: a do With the incr 2023 12 20
38076879 10.1101/2023Profiling the Metabolic dys 2023 12 20
38076483 10.1016/j.bo Clinical and <i>COL2A1</i> 2023 12 11
38076448 10.1016/j.jceA Novel causeTransient inf 2023 12 11
38075699 10.3389/fgenCase report: Very Early On 2023 12 11
38075692 10.3389/fgenPrenatal gene<b>Objective: 2023 12 11
38075685 10.3389/fgenA pharmacogen <b>Introducti 2023 12 11
38075676 10.3389/fgenExpanding the<b>Background 2023 12 11
38075274 10.3389/fnin Identificatio <i>SHANK2</i> 2023 12 11
38075079 10.3389/fend<i>PAM</i> va Germline loss 2023 12 20
38075060 10.3389/fendCase Report: Pseudoachondr 2023 12 26
38074074 10.1093/bra Novel variant<i>CADM3</i> 2023 12 11
38073688 10.12998/wjcType II AberneAbernethy mal 2023 12 11
38073621 10.3389/fneuVulto-van Sil Vulto-van Sil 2023 12 11
38073519 10.1002/mggFirst preimpl Meckel-Gruber 2024 1 8
38073514 10.1002/mggExome sequenc Stickler synd 2024 1 8
38073250 10.1093/hmgComprehensive The UK Bioban 2023 12 11
38073178 10.1111/andrGenome sequen There are lik 2023 12 11
38073170 Why are you Inborn errors 2023 12 16
38073125 10.1111/epi. Common genes We aimed to i 2023 12 22
38072404 10.2169/inte Writer's CramSpinocerebell 2023 12 10
38072093 10.1016/j.ca Sudden unexpe A 28-year-old 2023 12 28
38071834 10.1016/j.ejoClinical and mTo present th 2023 12 25
38071801 10.1016/j.ja Loss of functiAnti-nuclear 2023 12 10
38071056 10.19746/j.cn[Preliminary To investiga 2023 12 16
38070824 10.1016/j.ej Progressive mNGLY1-associa 2023 12 13
38069551 10.1002/mggCharacterizatMSX1 (OMIM #1 2024 1 8
38069323 10.3390/ijmsRare A360T Mu Presenilin 1 2023 12 16
38069250 10.3390/ijmsDefect of <i> Thinning of t 2023 12 20
38068917 10.3390/ijmsNovel <i>CRYG Congenital ca 2023 12 16
38067377 10.3390/canc<i>POLD1</i>Mutations in 2023 12 9
38067373 10.3390/cancIntegrated GeProstate canc 2023 12 9
38067352 10.3390/cancClonality AnaHistologic tr 2023 12 9
38066582 10.1186/s129A novel truncHaploinsuffic 2024 1 16
38064009 10.1007/s102Anxiety and dGuanfacine is 2023 12 8
38063435 10.1002/pd.6Diagnosis of The value of 2023 12 8
38063144 10.1016/j.gi Most FanconiFanconi anemi 2024 1 19
38062992 10.1177/153 Assessments Toumor mutatio 2024 1 8
38062907 10.1111/cga. TBX5 pathogen Congenital tr 2024 1 17
38062767 10.1089/thy. Presumed Path <b><i>Backgro 2024 1 18
38062428 10.1186/s129Clinical featu Short-rib pol 2023 12 16
38062033 10.1038/s415Genetic risk There is a pa 2023 12 7
38061711 10.5021/ad.2Novel Compoun Autosomal rec 2023 12 20
38061527 10.1016/j.ij Dent disease Dent disease 2023 12 15
38060757 10.7759/cureGray Platelet Gray platelet 2023 12 7
38060040 10.1007/s004Whole exomeHereditary
s ic 2023 12 18
38059661 10.1002/pd.6A novel SMOC1 Trio exome se 2023 12 25
38058760 10.1159/000 <i>TRAPPC9</i Hereditary fo 2023 12 8
38058759 10.1159/000 Dandy-WalkerWe report on 2023 12 8
38058758 10.1159/000 Laboratory anNA 2023 12 8
38058757 10.1159/000 Sequence VarSplit hand an 2023 12 8
38058755 10.1159/000 Copy NumberInVhuman gene 2023 12 8
38058754 10.1159/000 Further EvideFanconi anemi 2023 12 8
38058752 10.1159/000 Identificatio Waardenburg s 2023 12 8
38058352 10.7759/cureClinical Pres Laryngeal can 2023 12 8
38058035 10.3760/cma.[Clinicopatho<b>Objective 2023 12 18
38057991 10.1002/ajmgMaternal CHDParental mosa 2023 12 7
38057902 10.1186/s130Prenatal diagFew co-occurr 2023 12 9
38057798 10.1186/s128Whole-exomeSmalls cell tr 2023 12 11
38057443 10.1038/s415Inferring comRecessive dis 2024 1 15
38057384 10.1038/s415Mutational spDuchenne musc 2023 12 11
38057357 10.1038/s415The diagnostiExome sequenc 2023 12 11
38057346 10.1038/s414Rare X-linkedAutism spectr 2023 12 11
38057311 10.1038/s413Integrative a Autism spectr 2023 12 11
38056891 10.1002/pd.6When shouldDetermine
w the 2023 12 6
38056433 10.1159/000 Expanding theIntroduction 2023 12 6
38055913 10.1200/JCO.Genetic CharaPrimary media 2023 12 6
38054560 10.1002/pd.6Monogenic con Determine the 2023 12 6
38054405 10.1016/j.gi Biallelic var SLC4A10 encod 2023 12 6
38054206 10.17179/excExploring mitLeber's hered 2023 12 7
38054200 10.1016/j.go Therapeutic tMost cervical 2023 12 7
38054185 10.3389/fpedA novel splici Duchenne musc 2023 12 7
38054088 10.3389/fcvmCase report: Dilated cardi 2023 12 7
38054026 10.3389/fgenChronic syste<b>Introducti 2023 12 7
38053936 10.1016/j.ymLysinuric pro Lysinuric pro 2023 12 7
38053933 10.1016/j.ymAn unusually Biotin-Thiami 2023 12 7
38053926 10.1016/j.ymPredicting theRare diseases 2023 12 7
38053262 10.1136/jcp- Genetic variaVon Willebran 2023 12 6
38053031 10.1186/s128Clinical and gThe study des 2023 12 15
38052906 10.1038/s414Association oCongenital ac 2023 12 5
38052765 10.1158/153 ERBB4-Mediate BTK and PI3K 2023 12 18
38051749 10.1371/jourA novel splic Founder varia 2023 12 7
38051303 10.1158/1055Genetic factoAn increased 2024 1 11
38049819 10.1186/s129A missense mu This study ai 2023 12 6
38048694 10.1182/blooLoss of CD20 CD20 is an es 2023 12 4
38048560 10.3171/CAS Genomic chara Esthesioneuro 2023 12 9
38046674 10.3389/fpedA novel homoz The mitochond 2023 12 5
38046281 10.2147/DDDRecombinantGenomic
H profi 2023 12 5
38046254 10.46497/ArcTreatment of This study ai 2023 12 5
38045411 10.21203/rs. Phenotype-DriRare disease 2023 12 14
38045317 10.1101/2023Early-onset s Rare variants 2023 12 4
38045215 10.1016/j.he <i>DCX</i> vaSubcortical b 2023 12 5
38043837 10.1016/j.ge A novel APC m Gardner syndr 2024 1 12
38042015 10.1016/j.myConcurrent inExophiala der 2023 12 2
38041684 10.1136/jnnpRecurrent <i>Amyotrophic l 2024 1 18
38041506 10.1002/mggComparison of The recent gu 2024 1 8
38040921 10.1007/s110Assessment ofColorectal ca 2023 12 15
38039962 10.1016/j.cceGenomic alterEsophageal sq 2023 12 16
38039877 10.1016/j.or Genomic andCutaneous squ 2023 12 25
jabbrv journal keywords lastname firstname address email
Curr Oncol R Current oncolNA Daly Gordon R The Departmen gordondaly@r
Mol Biol Rep Molecular bioNA Wu Min Jiangsu Key L NA
InflammophaInflammophaNA Afshari Havva Department of NA
Expert Opin TExpert opinioNA Chen Lin Department of NA
Front ImmunoFrontiers in NA Qin Yi Department of NA
Front ImmunoFrontiers in NA Rodriguez Galaxia M Cancer TherapNA
Heliyon Heliyon NA Tuncer Seref Bugra Department of NA
medRxiv medRxiv : theNA Chen Junyu NA NA
Iran J Basic MIranian journaNA Al-HarmooshAli Hussein Department of NA
Exp Ther MedExperimentalNA Fu Jiewen Key LaboratorNA
Eur J Obstet European jourNA Sala Valentina Unit of ObstetNA
Trials Trials NA Ye Dao-Xiong Department of NA
Cell CommunCell communic NA Gong Lanqing Department of NA
Int J Gynecol International NA Krankenberg David JohannGynecology wijohannes.krankenberg@charite.de
Mol Pharm Molecular phNA Deng Mengqi Beijing ObsteNA
ESMO Open ESMO open NA Benvenuti C Department of NA
Biomol Biom BiomoleculesNA Abujamous Lama Department of NA
Clin Cancer RClinical canceNA Wang Yinu NorthwesternNA
Cancer Med Cancer medicNA Kast K Center for HeNA
Cancer Med Cancer medicNA Wang Min Department of NA
Clin Obstet GClinical obsteNA Karlan Beth Y Department of NA
Cancer Rep ( Cancer reportNA Wu Kui Department of NA
J Biomed OptJournal of bi NA Liu Huazhen Chinese Acade NA
J Cancer Journal of Ca NA Machairiotis Nikolaos Third Departm NA
J Cancer Journal of Ca NA Yang YinRong Department of NA
Biomed Res I BioMed resear NA International BioMed ReseaNA NA
Gland Surg Gland surgeryNA Lee Dowon Department of NA
BMC Cancer BMC cancer NA Yu Jie-Hai State Key LabNA
Zhonghua Fu Zhonghua fu cNA Liang H Department of NA
Proc Natl AcadProceedings oNA Liu XF Laboratory ofNA
Mol Biol Rep Molecular bioNA Karimzadeh Mohammad RDepartment of NA
Aging (AlbanyAging NA Cao Lixue Medical ReseaNA
Analyst The Analyst NA Wang Kai-Hao Department of chelkc@ccu.edu.tw
Cancer Sci Cancer sciencNA Kang Huiram Department of NA
Int J Gen MedInternational NA Luo Yu Department of NA
iScience iScience NA Zhang Haobo Key LaboratorNA
J Ovarian ResJournal of ov NA Tu Hsin-Fang Department of NA
Oncogene Oncogene NA Liu Hanyuan Department of NA
J Ginseng ResJournal of gi NA Zhang Rong Department of NA
Afr Health SciAfrican healt NA Habel A Laboratory ofNA
Int Med Case International NA Liu Yang Department of NA
Matrix Biol PlMatrix biologNA Neilson Lisa J Cancer ResearNA
Quant ImaginQuantitative NA Yang Lu Department of NA
Ann Med SurgAnnals of medNA Kudsi Maysoun Faculty of MeNA
AMIA Annu SAMIA ... Ann NA Nguyen Emily Computer Scie NA
Cureus Cureus NA Al Shamousi Khalid Medicine, Su NA
Asia Pac J Cli Asia-Pacific j NA Wen Xiao-Ting Department of NA
Pediatr Dev PPediatric and NA El Emrani Salma Department of NA
J Gynecol Ob Journal of gy NA Xie Lingyun Shanghai KeyNA
Eur J Surg OnEuropean jourNA Tozzi Roberto Department of roberto.tozzi@unipd.it
Eur J Obstet European jourNA Nie Xianglin Department of NA
Pathol Res PrPathology, reNA Tuncer Seref Bugra Department of seref.tuncer@istanbul.edu.tr
J Geriatr OncoJournal of gerNA Rittberg Rebekah Department of NA
J Cell Physiol Journal of celNA Lu Ping Department of NA
BMC WomensBMC women'sNA Zheng Jianfeng Department of NA
BMC WomensBMC women'sNA Huang Danxue Department of huangdanxue@163.com
Crit Rev OncoCritical revi NA Della Corte Luigi Department of NA
Nat Prod Res Natural produNA VeerapandiyaKandasamy Department of NA
J Ovarian ResJournal of ov NA Manzoor Hafiza BushraChronic DiseaNA
Reprod Sci ReproductiveNA Huang Xi Department of NA
Reprod Sci ReproductiveNA Gao Lvfen Department of NA
Nat NanotechNature nanotNA Huang Xiaowan School of Bio NA
Indian J Canc Indian journalNA Elkholy Enas Clinical Onco NA
Taiwan J ObstTaiwanese jouNA Chang Ting Yu Department of d29825@mail.cmuh.org.tw
Taiwan J ObstTaiwanese jouNA Lin Yu-Wei Department of NA
Taiwan J ObstTaiwanese jouNA Yang Szu-Ting Department of NA
J Gynecol OncJournal of gy NA Shim Hyoeun Department of NA
J Gynecol OncJournal of gy NA van WagensveLilian Department of l.vanWagensveld@iknl.nl
Life Sci Life sciences NA Gala Kavita Sunandan Diva NA
Eur J Obstet European jourNA Malik Naushabah Shrewsbury an drnaushabah@gmail.com
Eur J Surg OnEuropean jourNA Yang Dong Department of NA
J Inorg Bioch Journal of in NA Tr&#xe1;vn&Zden&#x11b;Regional Centzdenek.travnicek@upol.cz
Gynecol OncoGynecologic NA Gressel GM Corewell Healgregory.gressel@corewellhealth.org
Am Fam PhysiAmerican fami NA Wheeler Vernon Carl R. Darna NA
J Clin Oncol Journal of cli NA TjokrowidjajaAngelina National HealNA
PLoS Pathog PLoS pathogeNA Wang Shaowei State Key LabNA
Eur J EpidemiEuropean jourNA Fang Aiping Department of NA
Cancer EpideCancer epidem NA Chen Dongbo NorthwesternNA
ACS Sens ACS sensors NA Veliz Lorena Department of NA
Recent Pat AnRecent patentNA Tang Qiong Department of NA
Int J Oncol International NA Grunt Thomas W Cell Signalin NA
J Cancer Journal of Ca NA Wu Hongze Department of NA
Int J Cancer International NA Wang Xiaojiang Key LaboratorNA
J Transl Med Journal of tr NA Li Yu-Kun Department of NA
BMC Endocr DBMC endocrinNA Zhuang Yong Department of NA
Lancet Digit The Lancet. DiNA Cai Guangyao Department of NA
Pathology Pathology NA Wong Richard WingDepartment of wwc091@ha.org.hk
Asian J Surg Asian journal NA Luo Xue Department of NA
J Nucl Med Journal of nucNA Unterrainer Lena M Ahmanson Tran lunterrainer@mednet.ucla.edu
Zhongguo ZhoZhongguo Zhon NA Tang Mao-Yan Heilongjiang NA
Cell Signal Cellular signalNA Huang Jiazhen Department of NA
Free Radic Bi Free radical NA Zhao Shuhua Department of NA
Gynecol OncoGynecologic NA Szamreta Elizabeth A Center for O elizabeth.szamreta@merck.com
Cancer Res Cancer resea NA Shah Shreya M Fox Chase CanNA
JCO Glob OncJCO global onNA Al Sukhun Sana Al Hyatt OncoNA
Int J GynaecoInternational NA Wang Jing Obstetrics anNA
Mol Cancer TMolecular canNA Suzuki Hirokazu Daiichi-SankyNA
J Obstet GynaJournal of ob NA Khadilkar Suvarna SatisThe FederatioNA
J Obstet GynaJournal of ob NA Begum Dimpy Department of NA
Hum Reprod Human reprod NA Grubliauskai Monika Institute of B NA
Int J Mol Sci International NA Ko&#x15b;nikWioletta NanoVelos S.NA
Int J Mol Sci International NA Fantone Sonia Scientific Dir NA
Int J Mol Sci International NA Xia Tianxiang Department of NA
Int J Mol Sci International NA Chac&#xf3;n Carlos Laboratorio NA
Int J Mol Sci International NA Almeida-NunDiana Lu&#xeDifferentiatioNA
Int J Mol Sci International NA Rivas-Garc&#Lorenzo Department of NA
Int J Mol Sci International NA Dias Nunes Joana Research LabNA
Int J Mol Sci International NA Marques In&#xea;s SoaMolecular Onc NA
Int J Mol Sci International NA Zhong Qiu-Hua Laboratory ofNA
Molecules Molecules (BaNA Lim Ye Jin Department of NA
Cancers (BaseCancers NA Poplawski Tomasz Department of NA
Cancers (BaseCancers NA Ulevicius Jonas Laboratory ofNA
Cancers (BaseCancers NA Morgan Robert D Department oNA
Cancers (BaseCancers NA Rebord&#xe3;Mariana Medical OncolNA
Cancers (BaseCancers NA Xi Qian Division of I NA
Cancers (BaseCancers NA Gasimli Khayal Department of NA
Cancers (BaseCancers NA Liu Taoran Department of NA
Cancers (BaseCancers NA Schreiber Anna R Division of MNA
Cancers (BaseCancers NA G&#xf3;mez-VFern&#xe1;n Department of NA
Cancers (BaseCancers NA Lakhiani Aarti Institute of NA
Cancers (BaseCancers NA Turinetto Margherita Department of NA
Cancers (BaseCancers NA Fr&#x105;szcKarolina st Chair and NA
Diagnostics (BDiagnostics (BNA Laios Alexandros Department of NA
Diagnostics (BDiagnostics (BNA Yu Jinghan Department of NA
Cells Cells NA Libbrecht Sarah Life Science NA
Nat Med Nature medicNA Sosinsky Alona Genomics EngNA
Sci Rep Scientific rep NA Yumru Celiks Harika Department of harika.yumru@istanbul.edu.tr
Occup EnviroOccupationalNA Renier Marine Institut Nati marine.renier@unicaen.fr
Exp Cell Res ExperimentalNA Zhang Yun Department of sparkice818@163.com
J Inorg Bioch Journal of in NA Menon Vijay Massey CanceNA
Eur J Nucl M European jourNA Li Xiang Department of NA
Cancer Res Cancer resea NA Wang Chien-Wei University of NA
J Gastrointes Journal of gasNA Smith Jarrod T Department of NA
Geroscience GeroScience NA Sze&#x151;csD&#xf3;ra Department of NA
Br J Cancer British journaNA Young Han Chae Department of NA
Commun BiolCommunicatio NA Gong Ting-Ting Department of NA
Cell Death Di Cell death &aNA Fu Xin Tianjin Medicxinfu@tmu.edu.cn
Biol Reprod Biology of re NA So Wonmi Olson Center NA
Biomed Phar Biomedicine NA Asif Kanwal Pathology UniNA
J Clin Oncol Journal of cli NA Han Chae Young Department of NA
Clin Transl M Clinical and t NA Xie Fanfan Department of NA
J Korean MedJournal of Ko NA Choi Yae Ji Department of NA
Int J WomensInternational NA Nagarkar Rajnish Surgical OncoNA
Bioeng Trans BioengineerinNA Zhang Liyuan School of BasNA
Cureus Cureus NA Ranjith Saanthwana Obstetrics anNA
Oncol Lett Oncology lettNA He Xingting Department of NA
Front Nutr Frontiers in nNA Gu Haitao Department of NA
EClinicalMediEClinicalMediNA Lacaze Paul School of PubNA
Nutr Diet Nutrition &amp NA Johnston Elizabeth A Population HeNA
Technol CanceTechnology i NA Zhong Ailing Department of NA
NPJ Precis OnNPJ precisionNA Fang Yiming Indiana UniveNA
Sci Rep Scientific rep NA Galpin Kristianne J CCancer TherapNA
J Racial Ethn Journal of racNA James Sarah E Department oJames.sarah1@mayo.edu
BMC Med BMC medicinNA Wang Yuwei Division of MNA
BMC Cancer BMC cancer NA Weigelt Jil Institute of jilweigelt@googlemail.com
Am J Obstet American jourNA How Jeffrey A Department of NA
Gynecol Obste Gynecologie, NA Taris Nicolas Unit&#xe9 n.taris@icans.eu
JCO Oncol PraJCO oncologyNA Kamath Suneel D Cleveland ClinNA
J Womens Hea Journal of woNA Stuenkel Cynthia A Department of NA
Breastfeed MBreastfeedingNA Schwarz Eleanor B Division of GeNA
J Biomol Stru Journal of bi NA Paul Sanjay KumarDepartment of NA
Dalton Trans Dalton transaNA Liang Chun-Jie Guangxi Key Lqpqin2018@126.com
Ther Adv MedTherapeutic aNA Hong XinYi Department of NA
Ther Adv MedTherapeutic aNA KrishnamurthNithya Icahn School NA
Ther Adv MedTherapeutic aNA Kubota Yohei Department of NA
Front Oncol Frontiers in NA Brassard Julyanne School of Bio NA
Indian J Surg Indian journalNA RamachandraAmrutha Department of NA
Indian J Surg Indian journalNA Joshi Shalaka Department of NA
Indian J Surg Indian journalNA Dash Biswajit GynaecologicNA
Front ImmunoFrontiers in NA Fan Zhongru Department of NA
Heliyon Heliyon NA van der PloegPhyllis Department of NA
Am J Cancer American jourNA Song Mihae Division of G NA
Am J Cancer American jourNA Zhang Kai Department of NA
Am J Transl RAmerican jourNA Li Chao Department of NA
J Family Med Journal of fa NA Tauseef Abubakar Department of NA
Oncol Res Oncology res NA Wu Jianfa Department oNA
Indian J Canc Indian journalNA Chandy Rachel G Department of NA
Thorac CanceThoracic cancNA Ju Jie Department of NA
Genome MedGenome mediNA Auwerx Chiara Center for In chiara.auwerx@unil.ch
Transl Oncol Translational NA Zhu Qiuli Department of NA
Mol BiotechnMolecular bi NA Kou Junyan Oncology Depa NA
Diagn Pathol Diagnostic paNA Vogel Anne Institute of NA
Mol Cancer Molecular ca NA Li Han Department of NA
Eur J Med Re European jourNA Li Pu-Chun PostgraduateNA
J Virol MethoJournal of vi NA Hunter-SchlicDeVon N Masonic Cance NA
Eur J Surg OnEuropean jourNA Nikiforchin Andrei Surgical OncoNA
Acta Obstet Acta obstetri NA Bohlin Katja Stenstr Department oNA
Tumori Tumori NA Barcellini Amelia Radiation OncNA
Commun BiolCommunicatio NA Zhang Linan Department of NA
NPJ Precis OnNPJ precisionNA Jiang Lindong Tulane CenterNA
Cancer Sci Cancer sciencNA Liu Jia Department of NA
J EthnopharmJournal of e NA Chen Hongmei The First Sch NA
Gene Gene NA Ahmadpour Sara BiotechnologyNA
Biochim BiophBiochimica etNA Zhu Qingjuan N19 District 18959779688@163.com
J Clin Endocr The Journal oNA Ramchand Sabashini K Department of NA
Medicine (BalMedicine NA Khanmammad Ni Jat Department of NA
Biomed MicroBiomedical mNA Y&#x131;lmaMerve Faculty of Sc NA
Front Biosci Frontiers in NA Hua Li The School ofNA
Case Rep OncCase reports NA Mendes GomLuciana BeatrOncology Cente NA
Cureus Cureus NA Bahall Vishal Obstetrics anNA
ACG Case RepACG case repoNA Garcia Alexander Department of NA
Mater Today Materials todNA Khunmanee Sureerat Department of NA
J Gynecol OncJournal of gy NA Lee Banghyun Department of NA
J Gynecol OncJournal of gy NA Kanno Motoko Department of motoko.kanno@jfcr.or.jp
J Gynecol OncJournal of gy NA Takahashi Yoshifumi Department of ytakahashi@jichi.ac.jp
J Ovarian ResJournal of ov NA Shi Huihui Department of NA
Diagn Pathol Diagnostic paNA Wang Jinfeng Department of NA
Diagn Pathol Diagnostic paNA Xiong Tingchuan Department of NA
BMC Pregnanc BMC pregnanc NA Gama Qujia Department of NA
Oncogene Oncogene NA Wu Chin-Jui Department of NA
PET Clin PET clinics NA Lee Elaine Yuen PDepartment of eyplee77@hku.hk
Gynecol OncoGynecologic NA AlSomairi Amal Department of NA
Obstet GynecObstetrics anNA Greenwood Ashley Divisions of NA
JCI Insight JCI insight NA Sveen Anita Institute for NA
Aging (AlbanyAging NA Xu Yan Department oNA
Aging (AlbanyAging NA Gao Yang Department of NA
Cancer Cancer NA Bhatt Rikesh Department of NA
Mol CarcinogMolecular carNA Liu Xiaoli Department of NA
Expert Rev AnExpert reviewNA Zhou Shulin Department of NA
Cureus Cureus NA Chauhan Urvi S Pathology, DaNA
Zhongguo Yi Zhongguo yi xNA Qin De-Han Department of NA
Curr Cancer DCurrent canceNA Guo Yanglong Department of NA
Diagn Pathol Diagnostic paNA Shahi Maryam Department oShahi.Maryam@mayo.edu
World J Surg World journalNA Zhang Wei Clinical Labo NA
Clin ProteomiClinical prot NA Ryu Joohyun Department of NA
Commun MedCommunicatio NA Aggarwal Arpit Georgia Tech,NA
Curr Treat OpCurrent treatNA Anastasio Mary Katheri Department omm765@duke.edu
Lab Anim (NYLab animal NA Le Bras Alexandra Lab Animal, . alexandra.lebras@nature.com
Sci Rep Scientific rep NA Hu Xianwen Department of NA
Ceska GynekoCeska gynekoNA Siskov&#xe1;Ingrid NA NA
Proteomics Proteomics NA Yue Liang School of Lif NA
J Reprod ImmJournal of re NA Farahani Hadiseh Department of NA
Curr Opin ObsCurrent opiniNA Garc&#xed;a-IDavid GynaecologicNA
Curr Opin ObsCurrent opiniNA Ali Maryam Herbert Werth NA
Curr Opin ObsCurrent opiniNA Salutari Vanda Gynaecology N OA
Mol Biol Rep Molecular bioNA Akar Sakine Department of ylmzsakine@gmail.com
Int J NanomedInternational NA Xu Weibing College of Sc NA
Heliyon Heliyon NA Sadeghi Somaye ReproductiveNA
Front Oncol Frontiers in NA Zhang Hui Department of NA
J Cancer Journal of Ca NA Zhao Jing Department of NA
J Cancer Journal of Ca NA Zhang Zihui Department of NA
Int J Biol Sci International NA Wu Min East China NoNA
Autophagy Autophagy NA Bildik Gamze Department of NA
Childs Nerv S Child's nervouNA Gupta Anya Departments NA o
Sci Rep Scientific rep NA CharoenkwanKittipat Division of G NA
Res Sq Research squNA Hwang Sung-Min Department of NA
bioRxiv bioRxiv : the NA Huang Huaizhi NA NA
bioRxiv bioRxiv : the NA Johnston Adrian C NA NA
Sci Rep Scientific rep NA Xu Kejun Gynaecology N aA
Cell CommunCell communic NA Iqbal Muhammad JDepartment of NA
BMC WomensBMC women'sNA Chen Sheng Oncology Depa NA
BMC WomensBMC women'sNA Fang Chenyan Department of NA
BMC Cancer BMC cancer NA Ghasemian Majid Department of NA
Nutr Cancer Nutrition andNA Chen Kai The First Peo NA
BMC GenomicBMC genomicNA Zhao Zhihao Institute (Col NA
PLoS One PloS one NA Yoo Min Young Department of NA
J Clin Invest The Journal ofNA Wang Yinu Department oNA
Mol Biol Rep Molecular bioNA Chen Jiayao Department of chenjiayaozsyy@163.com
Ther Adv RepTherapeutic aNA Alter Roie Department of NA
Theranostics Theranostics NA Wang Luhui Department of NA
Front ImmunoFrontiers in NA Blanc-DurandFelix Department of NA
Cell Mol GastCellular and NA ChotiprasidhiPerapa Division of G NA
Front ImmunoFrontiers in NA Tan Qing Department of NA
Front Public Frontiers in pNA Lertwilaiwitt Pongtawat Department of NA
Asian J PharmAsian journal NA Zhong Min Department of NA
Reprod Sci ReproductiveNA Silber Sherman J Infertility Ce drsherm@infertile.com
Best Pract ReBest practice NA Sassarini Jenifer Consultant inNA
J Med Genet Journal of meNA Innella Giovanni Dipartimentogiovanni.innella2@unibo.it
Int J Gynecol International NA Chen Tingting Department oNA
Reprod BiomeReproductiveNA Ata Baris Department of Barisata@ku.edu.tr
Gynecol OncoGynecologic NA Wu Miao-Fang Department of NA
Endokrynol PEndokrynologiNA Bry&#x15b; Tomasz KrzyszClinical Depa NA
Oncologist The oncologisNA Yang Xiling Center for TraNA
Int Wound J International NA Zhang Qifan Department of NA
Cell Mol Biol Cellular and NA Feng Xue Department of fengxue1116@126.com
Genet Med Genetics in me NA Hanson Helen Peninsula Cli NA
Asian Pac J C Asian Pacific NA Farzaneh Farah Preventative NA
Front Oncol Frontiers in NA Zhang Shasha Department of NA
Nagoya J MedNagoya journa NA Kotaka Saki Department of NA
Histopatholo Histopatholo NA K&#xf6;bel Martin Department of NA
Indian J Canc Indian journalNA Cheng Lifang Department of NA
J NeuroimmuJournal of n NA Wadi Lara Duke Universilara.wadi@duke.edu
Methods Methods (SanNA Lo Yuan-Pin Department of NA
Lab Invest Laboratory inNA Heublein Sabine Department of Sabine.heublein@med.uni
Value Health Value in healtNA Wu Dongdong Department of NA
Pathol Res PrPathology, reNA Zhi Duo Department of NA
Biomed Phar Biomedicine NA S&#x142;yk &#x17b;anet Department of zaneta.slyk@wum.edu.pl
Gut MicrobesGut microbesNA Cross Tzu-Wen L Department of NA
Front Genet Frontiers in gNA Zhan Jun Department of NA
Front Oncol Frontiers in NA Brezis Miriam R Division of OnNA
Front EndocriFrontiers in NA Ruan Xiangyan Department of NA
Int Wound J International NA Xue Ying Department of NA
Nat Cancer Nature canceNA Payton Marc Oncology Resmpayton@amgen.com
Cold Spring Cold Spring HNA Yadav Siddhartha Department oyadav.siddhartha@mayo.edu
Int Immunop Internationa NA Jiang Fang Department of NA
Gynecol OncoGynecologic NA Altmann J European Comp Judith.altmann@charite.de
Gynecol OncoGynecologic NA Penvose Katherine N Duke UniversiNA
JAMA JAMA NA Harris Emily NA NA
PharmacoecoPharmacoEcoNA Lewis Diedron School of Pubdiedronlewis@gmail.com
Int Immunop Internationa NA Dong Xinhuai Central LaborNA
FEBS Open BiFEBS open bi NA NA NA NA NA
Autops Case Autopsy &amp NA Kumar Kaushlendra Dr. Ram Manoh NA
Med Oncol Medical oncoNA Y&#x131;ld&Melis RahimeDepartment of NA
In Vivo In vivo (Athe NA Oh Soo Hyun Department of NA
In Vivo In vivo (Athe NA Park Soo Jin Department of NA
In Vivo In vivo (Athe NA An Hyo Jung Department of NA
Gynecol OncoGynecologic NA Murayama Anju School of Medanju.murayama.s8@dc.tohoku.ac.jp
Acta Pharm Acta pharmace NA Okro&#x161;Ana Dugonji&Agency for Me NA
Methods MolMethods in mol NA Brownlie Rebecca J Leeds Institu NA
Oncotarget Oncotarget NA Ray Upasana NA NA
Cancer EpideCancer epidem NA Lee Mihye St. Luke's Int NA
Chembioche ChembiochemNA : Oliveira Laiane S State UniversNA
Int J GynaecoInternational NA Demissie Legesse Department of NA
Front Oncol Frontiers in NA Tasc&#xf3;n Laura Department of NA
Front Oncol Frontiers in NA Hughes Tirion University of NA
Front ImmunoFrontiers in NA Nasiri Fatemeh Department of NA
Cancer CausesCancer causesNA Craver Andrew Institute for NA
Onco TargetsOncoTargets NA Zhang Anqing Gynaecology N DA
Mol Ther Onco Molecular theNA Ye Yanqi ViroMissile, I NA
Front Oncol Frontiers in NA Gan Wenli Department of NA
ACS Omega ACS omega NA Wu Linlin Department of NA
J Obstet GynaJournal of ob NA Pradhan Rajashree Department of NA
Front Cell DevFrontiers in NA Kelly Tanya E Department of NA
Front ImmunoFrontiers in NA Guo Yaping Department of NA
Front PharmaFrontiers in NA Ma Xijun Neck-Shoulder NA
Hum Reprod Human reprod NA Maignien C Facult&#xe9 NA
Rev Bras GineRevista brasilNA Santiago Aline EvangelDepartment of NA
J Reprod ImmJournal of re NA Ito Yui Laboratory ofNA
FASEB J FASEB journalNA NA NA NA NA
Cancer CommCancer commu NA Raab Monika Department of NA
Vaccines (BasVaccines NA Mahasongkr Kodchakorn Center of ResNA
Int J Mol Sci International NA Conforti Roc&#xed;o Facultad de NA
Int J Mol Sci International NA Alonso Jo&#xe3;o CaLaboratory o NA
Int J Mol Sci International NA Szubert Maria Department of NA
Int J Mol Sci International NA Magadeeva Svetlana Department of NA
Int J Mol Sci International NA Xu Zixin Department of NA
J Pers Med Journal of pe NA G&#xf3;mez RJuan Department of NA
J Pers Med Journal of pe NA Climent Maria TeresaMultidiscipli NA
Molecules Molecules (BaNA Safdar Sahar School of Bio NA
Molecules Molecules (BaNA Bai Dorottya Interdiscipli NA
Medicina (Ka Medicina (KauNA Dra&#x10d;aNata&#x161;Svjetlost Eye NA
Medicina (Ka Medicina (KauNA &#xd6;mero&Ethem Clinic of Pat NA
Medicina (Ka Medicina (KauNA Potorac Alina Doctoral SchoNA
Medicina (Ka Medicina (KauNA Choi Min Sung Department of NA
Life (Basel) Life (Basel, S NA Vali Saaliha HammersmithNA
BiomedicinesBiomedicinesNA Kim Hee Su Department of NA
BiomoleculesBiomoleculesNA Ershova Maria O Institute of NA
BiomoleculesBiomoleculesNA Luo Xiaomei Department of NA
Cancers (BaseCancers NA Gu Qiu-Ying Department of NA
Cancers (BaseCancers NA Trecourt Alexis Service de PaNA
Cancers (BaseCancers NA Miceli Valentina Department of NA
Cancers (BaseCancers NA Abuzinadah Nihal Faculty of Co NA
Cancers (BaseCancers NA Chrysafi Pavlina Department oNA
Cancers (BaseCancers NA Jung Hye-Ji Gynecologic CNA
Cancers (BaseCancers NA Ceccaroni Marcello Department of NA
Cancers (BaseCancers NA Calheiros Juliana LAQV/REQUIM NA
Cancers (BaseCancers NA Andreou Maria Department of NA
Int J Gynecol International NA Cappuccio Serena Department of NA
Mol Cell EndoMolecular andNA Asa Sylvia L Department of Pathlady01@gmail.com
Gynecol OncoGynecologic NA Chan John K California Pa chanjohn@sutterhealth.org
Eur J Med Ch European jourNA Li Xinxin Jiangsu Key L NA
Medicine (BalMedicine NA Zhang Jie Central LaborNA
Medicine (BalMedicine NA Son Yu-Jung Research InstiNA
Nanomaterials Nanomaterials NA Geka Georgia Immunoassays NA
Curr Issues MoCurrent issueNA Bahmad Hisham F The Arkadi M.NA
Curr Issues MoCurrent issueNA Dzhugashvili Ekaterina V. Zelman InsNA
Curr Issues MoCurrent issueNA Albanna Haya College of Sc NA
Curr Oncol Current oncolNA Brault Claud&#xe8;lDepartment of NA
Curr Oncol Current oncolNA Gideonsson Ida Center of Ob NA
Curr Oncol Current oncolNA Sowamber Ramlogan Department of NA
Curr Oncol Current oncolNA Zadabedini MTahereh Clinical Epid NA
Biology (BaselBiology NA Wang Ji Indiana UniveNA
JMIR Med InfJMIR medicalNA Han Sungjoo Division of S NA
Genet Med Genetics in me NA Nolan Joshua Radcliffe DepNA
Eur Heart J C European hear NA Ajluni Steven C Department of NA
Mater Today Materials todNA Liu Qiyu Obstetrics anNA
Transl CancerTranslational NA Wu Jiacong Department of NA
South Asian JSouth Asian j NA Barmon Debabrata Department of NA
J Gynecol OncJournal of gy NA Chen Yulian Ovarian CanceNA
J Int Med ResThe Journal oNA Ye Liuqing Zhejiang CancNA
J Transl Med Journal of tr NA Zhou Xiaofang Department of NA
Cancer Cell InCancer cell inNA Wang Guichun School of Tra NA
Sci Rep Scientific rep NA Najafi Atefeh Department of NA
Sci Rep Scientific rep NA Wang Wangbiao Department of NA
Sci Rep Scientific rep NA Alalawy Adel I Department of NA
Acad Radiol Academic radNA Bi Qiu Department of NA
Int J Gynecol International NA Lorusso Domenica Istituto Tumokettalorusso@libero.it
Crit Rev OncoCritical revi NA Bao Wanying Department of NA
Biomed Phar Biomedicine NA Ma Qihong School of LifeNA
PLoS One PloS one NA Tao Fangfang NA NA
Minerva Endoc Minerva endoNA Aslam Baseer Dow Medical baseermuhammad02@gmail.com
Protein Cell Protein &amp; NA Lu Huifen Advanced Inno NA
Cancer Res Cancer resea NA Subbiah Vivek Sarah Cannon,NA
Front Oncol Frontiers in NA Schultz Iman J Pantarhei OncNA
Breast Care ( Breast care (BNA Jackisch Christian Department oNA
Breast Care ( Breast care (BNA Speiser Dorothee HBOC-Center,NA
Cancer InnovCancer innovaNA Zhao Qian Medical OncolNA
Front Nutr Frontiers in nNA Jiang Zongze Department of NA
Exp Ther MedExperimentalNA Zhang Yixin CollaborativeNA
Evid Based C Evidence-basNA And AlternatiEvidence-BasNA NA
Stem Cell ResStem cell res NA Lee Jin Woo Department of NA
J Med Genet Journal of meNA Panchal Seema University of NA
J Med Genet Journal of meNA Abe Akiko Cancer Instit akiko.abe@jfcr.or.jp
Sci Rep Scientific rep NA Huang Zhenglin North China I2970558385@163.com
Biol Reprod Biology of re NA Yu Seok-Yeong Olson Center NA
BMJ Case RepBMJ case repoNA Hannon Maura Obstetrics anmaurahannon@gmail.com
Zhonghua Yi XZhonghua yi xNA Shi PJ Department of NA
Zhonghua Fu Zhonghua fu cNA Zhang YL Department of NA
Zhonghua Fu Zhonghua fu cNA Fan RJ Department of NA
Int J Gynecol International NA Mangla Mishu Department of NA
Crit Rev OncoCritical revi NA Wang Yicong Department of NA
Acta BiomateActa biomaterNA Song Na Ministry of E NA
Cell Rep MedCell reports. NA Pozzorini Christian SOPHiA GENET NA
Cell Rep MedCell reports. NA Li Yang Department of NA
Expert Rev P Expert reviewNA Jordan Helen A Department of NA
Iran J Pharm Iranian journaNA Afshari Havva Department of NA
Reumatismo Reumatismo NA Sanghavi N Westchester M sang.nirali@gmail.com
Medicine (BalMedicine NA Jin Xiaofeng Department of NA
Medicine (BalMedicine NA Xu Ye GynecologicalNA
Medicine (BalMedicine NA Huang Yangyang Department of NA
Medicine (BalMedicine NA Wang Lei Department of NA
J Obstet GynaThe journal oNA Takahashi Yoshifumi Department of NA
Eur J Med Re European jourNA Chen Jia Department of NA
J Med Case RJournal of meNA Cabitza Eleonora Oncology, AziNA
J Ovarian ResJournal of ov NA Zhang Mengjun Department of NA
J Ovarian ResJournal of ov NA Ma Yimin Department of mayimin627@hotmail.com
Nat Rev Clin Nature reviewNA Sidaway Peter Nature Review peter.sidaway@nature.com
Sci Rep Scientific rep NA Biega&#x142;&#x141;ukaszDepartment of NA
Sci Rep Scientific rep NA Topalov NE Department oNicole.Topalov@med.uni
BMJ Case RepBMJ case repoNA Sheokand Seema Obstetrics anNA
Histopatholo Histopatholo NA Kommoss Felix K F Institute of NA
Int J Gynecol International NA Angeles Martina Aida Vall d'Hebronmartinangeles22@hotmail.com
Biochim BiophBiochimica etNA Wang Aihong Department of NA
ChemotherapChemotherapNA Bese Tugan NA NA
Eur J Oncol NEuropean jourNA Nic Giolla Ch Ciara Oncology-Haem ciara.nicgiollachomhaill@hse.ie
Hormones (AtHormones (AtNA Loizzi Vera S.S.D. GinecolNA
Cancer Res Cancer resea NA Sottnik Joseph L Department of NA
J Adolesc YouJournal of ad NA Chamani Isaac J Division of R NA
Expert Rev MExpert reviewNA Lee Jua Proteomics CeNA
Cancer Med Cancer medicNA Fan Yadan Department of NA
Plast ReconstPlastic and r NA Goel Pedram From the DeparNA
Front Oncol Frontiers in NA Leng Yinping Department of NA
Expert Opin Expert opini NA Nakai Hidekatsu Department of NA
J Nanobiotec Journal of na NA Yan Jinfeng National Clin NA
Cancer Cell InCancer cell inNA Kwon Mi Jeong Vessel-Organ mjkwon94@knu.ac.kr
Histopatholo Histopatholo NA McCluggage W Glenn Department of NA
Sci Rep Scientific rep NA Kim Kyeonghui Department of NA
J Comput AssJournal of co NA Ghahremani Gary G From the Depa NA
Mol Cell EndoMolecular andNA Liu Boqun Center for ReNA
Mol Cell EndoMolecular andNA Shen Jing Department of NA
Cancer Rep ( Cancer reportNA Lotfalizadeh Narges Department of NA
Proc Natl AcadProceedings oNA Mishra Abhinava K Molecular CelNA
Jpn J Clin OncJapanese journ NA Shono Masato Department of NA
J Proteome RJournal of pr NA Ricci Alessandro Notified BodyNA
Cancer Bioth Cancer bioth NA &#xd6;zdemiBelma G&#xf6Selcuk UniverNA
Clin Cancer RClinical canceNA Zhou Ivvone University of NA
J Biomol Stru Journal of bi NA Caputa Dominic A Physics DeparNA
ACS Pharmacol ACS pharmacol NA Duda Jolene M Department of NA
Iran J Public Iranian journaNA Zhang Yuyang The Second De NA
bioRxiv bioRxiv : the NA Monavarian Mehri Division of MNA
J Cancer Sci CJournal of canNA Liang Yayun Dalton CardioNA
Trials Trials NA Hawranek Carolina Department oNA
Gynecol OncoGynecologic NA Kim Ji Hyun Center for GyNA
Gynecol OncoGynecologic NA Vasta Francesca M Department of NA
Fertil Steril Fertility and sNA Kipling Lauren M Department of NA
Crit Rev OncoCritical revi NA Zhang Chi Cancer CenterNA
Pathol Res PrPathology, reNA Bates Mark Department of batesma@tcd.ie
Tissue Eng R Tissue engineNA Park Soo Jin Department of NA
BMC Complem BMC compleme NA Guan Hao-Ru CollaborativeNA
Cancer Gene Cancer gene NA Lv Jia Department of NA
J ImmunotherJournal for i NA NA NA NA NA
Int J Gynecol International NA Bogani Giorgio Department of bogani.giorgio@gmail.com
Int J Gynecol International NA El Bairi Khalid Department ok.elbairi@ump.ac.ma
Gynecol OncoGynecologic NA Benoit Louise Gynecologic alouise.am.benoit@gmail.com
J Inorg Bioch Journal of in NA Du Ling-Qi Guangxi Key LNA
Pharmacol RePharmacologyNA Sooda Kartheek Department of NA
Cancer Cancer NA Lumish Melissa A Department of NA
Arch Pharm ( Archiv der PhNA El Hassab Mahmoud A Department of NA
Ann Surg OncAnnals of sur NA Vizzielli Giuseppe Department of giuseppevizzielli@yahoo.it
Mutagenesis Mutagenesis NA Horak Josef Department of NA
Mol Med RepMolecular med NA Zhao Chenge Department of NA
Expert Opin Expert opinioNA Perrone Umberto Unit of ObsteNA
Mol Ther Molecular theNA Luan Xiaojin Chongqing Key NA
J Cell Mol MeJournal of ce NA Li Lin Department of NA
BMC Med ImaBMC medical NA Wang Hai-Tao Department of NA
Eur J Hum GeEuropean jourNA Langlois Alec W R Department oNA
Br J Cancer British journaNA Herrington C Simon The Nicola MuNA
Br J Cancer British journaNA Zebic Danka SinikovNational Healdanka.zebic@sydney.edu.au
Sci Rep Scientific rep NA Li Bohan Department of NA
Int J Gynecol International NA Agusti Nuria Department oNAgusti@mdanderson.org
Biochim BiophBiochimica etNA Tadi&#x107; Vanja Division of MNA
Oncology Oncology NA Li Sijian Department of sijian@126.com
Gynecol OncoGynecologic NA Richardson Michael T Department of NA
Obstet GynecObstetrics anNA NA NA NA NA
JCO Precis OnJCO precisionNA Meric-BernstFunda University of NA
J Am Nutr AssJournal of th NA Hoyt Margaret Department of NA
Eur Rev Med European reviNA Wang Y-R Department of liuzengyou66@hotmail.com
Int J Mol Sci International NA Kechin Andrey Institute of NA
Cancers (BaseCancers NA Nemunaitis John Gradalis, Inc. NA
Fam Cancer Familial canc NA Chan James M Colorectal OnNA
Gynecol OncoGynecologic NA Kahn Ryan M Gynecology Se NA
Ann Clin TranAnnals of clinNA Jang Yoonhyuk Department of NA
Histopatholo Histopatholo NA Chen Wei-Yu Department of NA
J Genet CounJournal of ge NA Morrow April Implementatio NA
Gynecol OncoGynecologic NA Ledermann Jonathan A Department of j.ledermann@ucl.ac.uk
Breast CancerBreast cancerNA Albitar Maher Genomic TestiNA
Hum GenomicHuman genom NA Nousiainen Susanna Applied Tumor NA
Int J Mol Sci International NA Harbin Laura M Division of G NA
Front Genet Frontiers in gNA Yang Fan Department of NA
Aging (AlbanyAging NA Wang Wenjing School of MedNA
Genes (Basel)Genes NA C&#xf4;rtes Luiza Department of NA
Int J Cancer International NA Kim Yoo-Na Department of NA
Nat Genet Nature genetiNA Wilcox Naomi Centre for CaNA
JCO Precis OnJCO precisionNA Wineland Dylane Arcadia UniveNA
J Cell Mol MeJournal of ce NA Li Jianxiong Department of NA
Curr Issues Mo Current issueNA P&#xe1;l Margit Department of NA
Br J Cancer British journaNA Lee Jae Eun Portrai Inc., NA
Commun BiolCommunicatio NA Kotnik Emilee N Division of G NA
Medicine (BalMedicine NA Liu Jia Department oNA
Transl Oncol Translational NA Menzel Michael Institute of NA
Clin Cancer RClinical canceNA Lheureux Stephanie Princess MargNA
Front EndocriFrontiers in NA Zhang Jin Department of NA
Clin Cancer RClinical canceNA DiPeri Timothy P Department of NA
Gynecol OncoGynecologic NA Thomson John P Nicola MurrayNA
Int J GynaecoInternational NA Feghaly Iman Department of NA
Sci Rep Scientific rep NA Hollis Robert L Nicola Murrayrobb.hollis@ed.ac.uk
J Exp Clin CanJournal of ex NA Dall Genevieve Walter and EliNA
Cancer Disco Cancer discovNA NA NA NA NA
Anticancer ReAnticancer reNA Lopacinska-J Joanna Department of NA
J ImmunotherJournal for i NA Fu Yu Department of NA
Cells Cells NA Biega&#x142;&#x141;ukaszDepartment of NA
BMC Cancer BMC cancer NA Li Jianxiong Longgang DisNA
Gynecol OncoGynecologic NA Bruce Shaina F Washington Un brucesf@wustl.edu
Front Oncol Frontiers in NA Alenezi Wejdan M Department of NA
Cancer ImmuCancer immun NA Millar Douglas G Tumor Immuno NA
Clin Cancer RClinical canceNA Doe-Tetteh Seyram A Marie-Jos&#xNA
Asian Pac J C Asian Pacific NA Sukpan Panupong Department of NA
Genes (Basel)Genes NA Fierheller Caitlin T Department of NA
Int J Gynecol International NA Shahi Maryam NA NA
Cancer Sci Cancer sciencNA Tamura Ryo Department of NA
Ann Oncol Annals of oncNA Luen SJ Department of NA
Virchows ArcVirchows ArchNA Qu Jiani Department of NA
Front Oncol Frontiers in NA van der Mer Nerina C Division of H NA
Front Oncol Frontiers in NA Seborova Karolina Toxicogenomic NA
Gynecol OncoGynecologic NA Manavella Diego D Department of NA
Int J Mol Sci International NA Gonzalez-BosJesus Department of NA
Sci Rep Scientific rep NA Duchnowska Renata Oncology Depa NA
Gene Gene NA Waghela Bhargav N Gujarat BioteNA
Nat CommunNature commu NA Murciano-GorYonina R Department of NA
Front Oncol Frontiers in NA Shen Kefeng Department of NA
Zhonghua Er KZhonghua er ke NA Zheng RJ Department of NA
Hum GenomicHuman genom NA Wang Wen-Chung Department of NA
Gynecol OncoGynecologic NA Cheng Aoshuang Department of chengaosh@mail.sysu.edu.cn
J ImmunotherJournal for i NA Waks Adrienne G Harvard Medic NA
Front Genet Frontiers in gNA Wang Xuwen School of ComNA
Gynecol OncoGynecologic NA ElNaggar Adam West Cancer C aelnaggar@natera.com
Life Sci Allian Life science aNA Hlav&#xe1;&Viktor Biomedical CenNA
Ann Oncol Annals of oncNA Loveday C Division of G NA
EBioMedicineEBioMedicineNA Heddar Abdelkader Universit&#x NA
Clin Genet Clinical genetNA Maxwell Kara N Division of H NA
Taiwan J ObstTaiwanese jouNA Pai Angel Hsin-YuDepartment of NA
Am J Surg PatThe AmericanNA Hopkins Mark R Departments NA
J Adv Res Journal of ad NA Sun Tingting Department of NA
GastroenteroGastroenteroNA Yang Keming Clinical and NA
Front Oncol Frontiers in NA Sabatier Renaud Aix-MarseilleNA
Clin Case RepClinical case NA Algouneh Arash Schulich SchoNA
J Biol Chem The Journal ofNA Liu Peng School of LifeNA
Cancer Res Cancer resea NA Chen Owen J Goodman Cance NA
Cancers (BaseCancers NA Dumont Martine Genomics CenNA
J Ovarian ResJournal of ov NA Bao Yi-Ting Department of NA
J Natl Cancer Journal of theNA Safdar Nida S Department of NA
Cell Death DifCell death andNA Franca Monica M Unidade de ENA
Gynecol OncoGynecologic NA Tymon-RosariJoan R Department of NA
Brief Bioinfo Briefings in b NA Chen Qingjian State Key LabNA
Cancers (BaseCancers NA Alenezi Wejdan M Department oNA
J Ovarian ResJournal of ov NA Marchocki Zibi Department of NA
Genes (Basel)Genes NA Alenezi Wejdan M Department of NA
Cancers (BaseCancers NA Glassman Deanna Department of NA
Curr Med Sci Current medicNA Hu Peng-Zhi Center for Ex NA
Hum Mol GenHuman molecu NA Liu Faying Key LaboratorNA
JCO Precis OnJCO precisionNA Kraya Adam A Division of T NA
Case Rep WoCase reports NA Silva R Cancer BiologNA
J Ovarian ResJournal of ov NA Yang Hua Department of NA
Hum Reprod Human reprod NA Vanni Valeria Stella Universit&#x NA
Bosn J Basic Bosnian journNA Kim Seungyeon Department of NA
J Hum Genet Journal of hu NA Revathidevi SundaramoorHuman Genetic NA
Genome MedGenome mediNA Fierheller Caitlin T Department of NA
NPJ Genom MNPJ genomic NA Elkin Rena Department of NA
Int J Gen MedInternational NA Lu Nan Department of NA
Hum Hered Human herediNA Guan Zoe Department of NA
Hered CancerHereditary can NA Wallander Karin Department of NA
Eur J Hum GeEuropean jourNA Tucker Elena J Murdoch Child Elena.tucker@mcri.edu.au
J Biomol Stru Journal of bi NA Wadapurkar Rucha M MIT School o NA
Sci Rep Scientific rep NA Tomioka Keita Department of NA
Front Oncol Frontiers in NA Li Xianghan Research SchoNA
Int J Gynecol International NA Matrai Cathleen E NA NA
Front Genet Frontiers in gNA Hamdi Yosr Laboratory ofNA
ImmunotheraImmunotheraNA Ni Ying Department of NA
Clin Cancer RClinical canceNA Sztupinszki Zsofia Danish CanceNA
Genes (Basel)Genes NA Sohn Min-Hwan Precision MedNA
Diagnostics (BDiagnostics (BNA Chang Ting-Yu Department oNA
Nat CommunNature commu NA Zong Xuan Department of NA
NPJ Precis OnNPJ precisionNA Hollis Robert L Nicola Murrayrobb.hollis@ed.ac.uk
Front Oncol Frontiers in NA Doddato Gabriella Medical GenetiNA
Oncologist The oncologisNA Toh MingRen Duke-NationalNA
Ann Transl MAnnals of tra NA Su Dan Department oNA
Cancer Sci Cancer sciencNA Ono Rintaro Department of NA
Clin Cancer RClinical canceNA Takebe Naoko Division of C NA
Cancer Med Cancer medicNA Weberpals Johanne I Department of NA
Cancers (BaseCancers NA Amuzu Setor Department of NA
Cell Death Di Cell death di NA Chaudhry Sophia R Center for MoNA
Front Oncol Frontiers in NA Li Yuan Department of NA
Biol Reprod Biology of re NA Chen Juan Department of NA
Gynecol OncoGynecologic NA Filippova Olga T Department of NA
Diseases Diseases (BasNA Kurose Sonomi Department of NA
Cancer Res Cancer resea NA Shrestha Raunak Vancouver Pro NA
Front Oncol Frontiers in NA Jiang Xuan Department of NA
Gynecol OncoGynecologic NA Karnezis Anthony N Department of NA
Hum Mutat Human mutatNA Felicio Paula S Molecular Onc NA
BMC Cancer BMC cancer NA Tsutsumi Makiko Division of MNA
Front Genet Frontiers in gNA Mighri Najah Laboratory ofNA
Front Oncol Frontiers in NA Guo Yuanli Department of NA
Cancer ImmuCancer immun NA Dao Tao Molecular PhaNA
Cancer Prev RCancer prevenNA Mart&#xed;nLorena Molecular Onc NA
Nat CommunNature commu NA Hollis Robert L Nicola MurrayNA
J Pathol The Journal oNA Li Lihong Department of NA
Clin Chem Clinical chemiNA Long Dustin R Division of C NA
JCO Precis OnJCO precisionNA Liu Ying L Department of NA
JCO Precis OnJCO precisionNA Smith Evan S Memorial SloaNA
Gynecol OncoGynecologic NA Madariaga Ainhoa Division of NA
J Pathol The Journal oNA Cheasley Dane Cancer GenetiNA
Sci Rep Scientific rep NA Pongor L&#x151;rinc Department of NA
Elife eLife NA Felipe-MedinNatalia Molecular MeNA
Breast CancerBreast cancerNA Bagherzadeh Maryam Women's Colle NA
Am J Surg PatThe AmericanNA Zyla Roman E Department of NA
Mol Genet G Molecular geNA Wang Fei Department of NA
Neoplasia Neoplasia (NeNA Yang Qin Fengxian Hosp NA
J Med Genet Journal of meNA Shickh Salma Li Ka Shing K NA
Cells Cells NA Auguste Aur&#xe9;lie Medical OncolNA
Oncologist The oncologisNA Yuan Zhen Department of NA
J Assist Repr Journal of as NA Liu Mohan State Key LabNA
Cancer Sci Cancer sciencNA Suda Kazuaki Department of NA
J ImmunotherJournal for i NA Matsushita Hirokazu Department of NA
Clin Cancer RClinical canceNA Lheureux Stephanie Division of MNA
Gynecol OncoGynecologic NA Song Fangfang Department of NA
BMC Cancer BMC cancer NA Lung Mei Sim Research DiviNA
Ann Oncol Annals of oncNA Waks AG Department of NA
Lab Invest Laboratory inNA Schaafsma Evelien Department of NA
Gynecol OncoGynecologic NA Pierson William E Department of NA
Int J Mol Sci International NA Zolotovskaia Marianna A Oncobox ltd. NA
Br J Cancer British journaNA Masoodi Tariq Human Cancer NA
Cells Cells NA D'Ambrosio Concetta Candiolo CancNA
Nat CommunNature commu NA Nelson Louisa Division of C NA
Cancer Med Cancer medicNA Tian Wenjuan Department of NA
High ThroughHigh-throughNA Zelli Veronica Department of NA
J Assist Repr Journal of as NA Pashaei Mahdieh Genetics ReseNA
Mod Pathol Modern pathol NA Heskett Michael B Department oNA
Nat CommunNature commu NA Kim Sarah H Department of NA
Pathology Pathology NA Xu Hui Institute of NA
J Pathol The Journal oNA Le&#xf3;n-CasAlicia Department of NA
Front Genet Frontiers in gNA Glentis Stavros Division of MNA
BMC Cancer BMC cancer NA MatsubayashiHiroyuki Division of G h.matsubayashi@scchr.jp
J Pathol Clin The journal ofNA Khalique Saira Division of MNA
Int J Mol MedInternational NA Christophers Mikael KronbMolecular UniNA
Neuro Oncol Neuro-oncoloNA Rivero-HinojoSamuel Center for CaNA
Genes (Basel)Genes NA Dugo Matteo Platform of I matteo.dugo@istitutotumori.mi.it
Melanoma ReMelanoma reNA Johansson Peter A OncogenomicNA
Gynecol OncoGynecologic NA Bianchi Anna Department of NA
Swiss Med WkSwiss medicalNA Kraemer Dennis Institute of MNA
Hered CancerHereditary can NA Arvai Kevin J GeneDx, 207 NA
Int J Mol Sci International NA Concolino Paola Dipartimentopaola.concolino@policlinicogemelli
Int J Cancer International NA Zhu Qianqian Department of NA
NPJ Genom MNPJ genomic NA Bertelsen Birgitte Center for G NA
J ImmunotherJournal for i NA Liu Song Department of song.liu@roswellpark.org
Cancer Cancer NA Weitzel Jeffrey N Division of Cl NA
Cancer GenetCancer genetiNA Lopes Jaime L Center for MoNA
J Pathol The Journal oNA Xu Ao The First Affi NA
Pediatr TransPediatric tra NA Graf Madeline Department of NA
Cancer Biol T Cancer biolo NA Kryklyva Valentyna a DepartmentNA
Nat Genet Nature genetiNA Gulhan Doga C Department of NA
Pathol Res PrPathology, reNA Choi Youn Jin Department of NA
Sci Rep Scientific rep NA Klebanov Nikolai Wellman Cente NA
BMC Endocr DBMC endocrinNA Jiao Jiao Center of RepNA
J Med Genet Journal of meNA Paperna Tamar The Genetics NA
Transl NeurosTranslational NA Ehaideb Salleh N King AbdullahNA
Commun BiolCommunicatio NA Dorri Fatemeh Department of NA
Int J Gynecol International NA Veneris Jennifer TayloDepartment of Veneris@dfci.harvard.edu
Cancer Cell InCancer cell inNA Fernandez Marta Llaura Obstetrics anNA
Gynecol OncoGynecologic NA Bonazzoli Elena Department of NA
Proc Natl AcadProceedings oNA Li Charles Department of NA
J Pathol The Journal oNA Wu Ren-Chin Department of NA
Cancer Res TrCancer resea NA Li Lan Ying Department of NA
Hum Reprod Human reprod NA Lac V Department of NA
Gynecol OncoGynecologic NA Ashley Charles W Department of NA
JCO Precis OnJCO precisionNA Moujaber Tania Tania Moujabe NA
Genes ChromGenes, chromNA Tamura Ryo Department of NA
Fam Cancer Familial canc NA Fahiminiya Somayyeh Cancer ResearNA
Gynecol OncoGynecologic NA Van NieuwenEls Department of Els.vannieuwenhuysen@uzleuven.b
Mol Cancer RMolecular canNA Alexiadis Maria Hudson InstitNA
JAMA Oncol JAMA oncoloNA Lu Hsiao-Mei Ambry Genetics NA
Cancer Cell Cancer cell NA Kahles Andr&#xe9; ETH Zurich, DNA
Am J Hum GeAmerican jourNA Kasak Laura Institute of NA
Int J Gynecol International NA Choi Youn Jin Departments NAof
Discov Med Discovery meNA Han Chanhee Department of NA
J Ovarian ResJournal of ov NA Jiang Wei Department of NA
Nat CommunNature commu NA Hillman R Tyler Department of NA
Gynecol OncoGynecologic oNA Norris Eric J Levine CancerNA
Clin Cancer RClinical canceNA Deniger Drew C Surgery BrancNA
Gynecol OncoGynecologic NA Mueller Jennifer J Department of NA
J Pathol The Journal oNA Temko Daniel Evolution andNA
Int J Gynecol International NA Yang Lingyi NA NA
Oncotarget Oncotarget NA Kanke Yasuyuki Division of G NA
Hum Reprod Human reprod NA Katari Sunita Department of NA
Clin Cancer RClinical canceNA Bellone Stefania Department of NA
J Med Genet Journal of meNA He Wen-Bin Institute of NA
Gigascience GigaScience NA Neums Lisa Department of NA
Genet Med Genetics in me NA Buchanan Adam H Geisinger HeaNA
Gynecol OncoGynecologic NA Kim Se Ik Department of NA
Cold Spring HCold Spring HNA Wu Ren-Chin Department of NA
Nat CommunNature commu NA Labidi-Galy S Intidhar Department of NA
Eur J Med GeEuropean jourNA Bouman Arjan Department of NA
Cancer Res Cancer resea NA Yin Xia State Key LabNA
Cancer Cancer NA Le Gallo Matthieu Cancer GenetiNA
Am J Pathol The AmericanNA Murakami Ryusuke Department of NA
Oncotarget Oncotarget NA Dicks Ed Centre for CaNA
Cancer Res Cancer resea NA Chan Claire Hian TzDivision of MNA
Oncogene Oncogene NA Velmurugan K R Department of NA
Int J Cancer International NA Kim Jung Clinical Gene NA
Cancer Res Cancer resea NA EtemadmoghDariush Peter MacCallNA
J Pathol The Journal oNA Errichiello Edoardo Department of NA
 BMC GenomicBMC genomicNA Buckley Alexandra R Biomedical ScNA
PLoS One PloS one NA Stafford Jaime L Center for MoNA
J Gynecol OncJournal of gy NA Zhao Qianying Department of NA
Genet Med Genetics in me NA Syeda Mahrukh M Department of NA
Breast CancerBreast cancerNA Tavera-Tapia A Human GenetiNA
Fam Cancer Familial canc NA Fremerey Julia Department of NA
Cancer Disco Cancer discovNA Eckert Mark A Department of NA
Fam Cancer Familial canc NA Marafie Makia J Kuwait Medica marafie@yahoo.com
Proc Natl AcadProceedings oNA Zhao Siming Department of NA
Mod Pathol Modern pathol NA Rosa-Rosa Juan M Servicio de NA
Eur J Hum GeEuropean jourNA M&#xe4;&#xeKirsi University of NA
J Pathol The Journal oNA Choi Youn Jin Department of NA
Clin Cancer RClinical canceNA Liu Joyce F Department of liu@dfci.harvard.edu
Cancer Res Cancer resea NA Walton Josephine Wolfson WohlNA
J Cancer Journal of Ca NA Dong Anliang . Women's HoNA
h over long distances Jerry W. Shay O2 The microtubule destabilizer KIF2A regulates the postnatal establishment of neuronal cir
Medicine (BalMedicine NA Xu Qinghua Kunming Key NAL
NeurotherapeNeurotherapeu NA Chin Hui-Lin Division of G NA
Cureus Cureus NA Alghanmi Bushra M General PractNA
Front PediatrFrontiers in pNA Jin Jessica Division of N NA
BMC Med Gen BMC medical NA Yan Xu ReproductiveNA
Cancer Cell InCancer cell inNA Kim Dokyeong Precision MedNA
Nat Rev GeneNature reviewNA Kernohan Kristin D CHEO Research NA
Leg Med (TokLegal medicinNA Li Zehao Department of NA
PLoS One PloS one NA JambulingamDhanaprakas Institute of NA
STAR Protoc STAR protocoNA Yuan Jian NA NA
Mol Biol Rep Molecular bioNA Wang Miao Shanghai KeyNA
Curr Opin NeuCurrent opiniNA Nicolas Ga&#xeb;l Univ Rouen NNA
Exp Biol MedExperimentalNA Nunes Jo&#xe3;o PauLaboratory ofNA
Neurol GenetNeurology. GeNA Warman-CharJodi From the Depa NA
Curr GenomicCurrent genoNA Kour BhumandeepDepartment of NA
Neurol GenetNeurology. GeNA Rambani Vibhuti From the InstNA
Neurol GenetNeurology. GeNA Heide Solveig From the Gene NA
medRxiv medRxiv : theNA Al-Qazazi Ruaa NA NA
Am J Med Gen American jourNA Farris Joseph Center for In NA
Hereditas Hereditas NA Xu Nuo Department of NA
Nephrology (CNephrology (CNA Zhang Xiuzhen Department of NA
BMC Neurol BMC neuroloNA Hebbar Malavika Division of N NA
J Epidemiol GJournal of ep NA Abuzenadah Adel Faculty of Ap NA
J Clin Res PedJournal of cli NA Jeon Jooyoung Department of NA
Genet Med OGenetics in mNA Postma Alex V Department oNA
Glob Med GeGlobal medicaNA Sun Mei Graduate ColleNA
Glob Med GeGlobal medicaNA Li Weiran Graduate ColleNA
Glob Med GeGlobal medicaNA Zhou Feiyu Tianjin ChildrNA
Ann Indian A Annals of IndNA Khurana Shiffali Department of NA
Ann Indian A Annals of IndNA Gowda Vykuntaraju Department of NA
J Hum Genet Journal of hu NA Inoue Yuta Department oNA
Andrology Andrology NA Zhang Ying-Teng Department of NA
J Med Genet Journal of meNA Liu Caiyan Peking Union NA
J Med Genet Journal of meNA Higashimoto Ken Division of MNA
Am J Hum GeAmerican jourNA BalachandranSaranya Institute of NA
Heliyon Heliyon NA Srivastava Priyanka Genetic Metab NA
Mol Genet MMolecular genNA Chen Congli Department of NA
BMC Pediatr BMC pediatriNA Nagy Nikoletta Department of NA
Clin Genet Clinical genetNA Wang Ping Department of NA
HamostaseoloHamostaseoloNA Li Xiangui Department of NA
Acta OtorrinolActa otorrinoNA Reda Del BarrSara Servicio de Osara.reda@salud.madrid.org
Clin Kidney J Clinical kidneNA Li Tao Department of NA
World AllergyThe World AllNA Qi Zheng Institutes of NA
JOR Spine JOR spine NA Li Juyi Department of NA
Mol Vis Molecular visNA Liu Liyan State Key LabNA
Clin Genet Clinical genetNA Elkhateeb Nour Department of NA
Andrology Andrology NA Shi Fu Department of NA
Orphanet J RaOrphanet jourNA Bisschoff Michelle Focus area foNA
Clin Chim ActClinica chimicNA Zhao Qianqian Department of NA
Ophthalmol ROphthalmologNA Lin Siying National Inst NA
ParkinsonismParkinsonismNA Dhar Debjyoti Department of NA
Psychiatry RePsychiatry re NA Torrey E Fuller The Stanley Mtorreyf@stanleyresearch.org
Cell Rep Cell reports NA OstroverkhovDaria Department of NA
Pathol Res PrPathology, reNA Gharesouran Jalal Department of NA
Genome MedGenome mediNA Yin Gengshen Department of NA
BMC Med Gen BMC medical NA Tehrani FatehSahand Center for CoNA
Nat CommunNature commu NA Barrett Thomas F Department of NA
J Surg Res The Journal ofNA Zhang Xiaohui Key LaboratorNA
Medicine (BalMedicine NA Yang Fan Clinical Rese NA
Childs Nerv S Child's nervouNA Meunier Colombine Institut de P colombine.meunier@ipg.be
Neurooncol ANeuro-oncoloNA Macke Erica L The Steve andNA
Ann Transl MAnnals of tra NA Maa&#xdf; Johann GeorgInstitute of NA
Clin Kidney J Clinical kidneNA Sewerin Sebastian Division of N NA
Front ImmunoFrontiers in NA Iorgulescu J Bryan Department of NA
Reprod Sci ReproductiveNA Zhang Fengbin Department of NA
Graefes Arch Graefe's archNA Vaclavik Veronika Jules-Gonin Everonika.vaclavik@fa2.ch
Genet Med Genetics in me NA Regier Dean A School of PopNA
HaematologicHaematologicNA Feng Qianxi Center for GeNA
JACC CardioOJACC. Cardio NA Sharafeldin Noha Institute for NA
Turk J PediatrThe Turkish joNA Ate&#x15f; Burcu BerberDepartment of NA
Turk J PediatrThe Turkish joNA B&#xfc;y&#xfG&#xf6;n&#xfDepartment of NA
Int J Mol Sci International NA Pasquetti Domizia Section of GeNA
Int J Mol Sci International NA Bagyinszky Eva Department of NA
J Clin Med Journal of cli NA Borrell Antoni Barcelona CenNA
J Clin Med Journal of cli NA Xu Lin-Lin Renal DivisionNA
Cells Cells NA Lorenzo-GuerSara Lucila Department of NA
Nat Genet Nature genetiNA Artomov Mykyta Institute for mykyta.artomov@nationwidechildr
Eur J Hum GeEuropean jourNA Albuainain Fatimah Department of NA
Zhonghua Yan[Zhonghua yan NA Wang YC Tianjin Eye HoNA
J ImmunotherJournal for i NA Li Junyi Department of NA
Int J Legal M International NA Sun Weifen Shanghai KeyNA
Blood Adv Blood advancNA BhattacharyaRomit Broad Institu NA
J Genet CounJournal of ge NA Balcom Jessica R Department of NA
Hematology Hematology (NA Puli'uvea Christopher Department of NA
Ophthalmic GOphthalmic gNA Petersen Sekita Dalsg&Faculty of HeNA
Genome Res Genome reseNA Qiao Yi Eccles Instit NA
Proc Natl AcadProceedings oNA Clatot Jerome Division of N NA
Genet Med Genetics in me NA Rips Jonathan Department of NA
Adv Biomed RAdvanced bioNA Ahmadi ShadAzam Social WelfarNA
Heliyon Heliyon NA Nawaz Hamed Department of NA
Heliyon Heliyon NA Thys Liene Department of NA
Front EndocriFrontiers in NA Dallali Hamza Genetic typingNA
Front EndocriFrontiers in NA Zhu Hongdan Shaoxing Mate NA
Prostate The Prostate NA White Jason A Center for CaNA
Am J Med Gen American jourNA Uguen Kevin Service de G NA
J Am Acad DeJournal of t NA Salik Deborah Department odeborah.salik@hubruxelles.be
Am J Med Gen American jourNA Y&#x131;lmaMustafa Department of NA
Int J GynaecoInternational NA Ma Chunling The First Sch NA
Clin Case RepClinical case NA Khani Marzieh School of Bio NA
Heliyon Heliyon NA Grueso Cer&#Angie Lizeth Universidad dNA
Am J Transl RAmerican jourNA Xie Yunyun Department of NA
Clin Kidney J Clinical kidneNA Torra Roser Inherited Kid NA
Clin Kidney J Clinical kidneNA Robert Thomas Centre of NepNA
Zhonghua Er BZhonghua er bNA Lei YB Department of NA
Orthop Surg Orthopaedic NA Li Longqing Department of NA
Pathology Pathology NA Patton Ashley Department oNA
Asian J Surg Asian journal NA Zhang Peng Department of NA
BioengineereBioengineereNA Huang Jiacheng Department of NA
Nat CommunNature commu NA Amado Nathalia G Department of NA
Genome MedGenome mediNA Due&#xf1;as Alfredo Center for MeNA
Am J OphthalAmerican jouNA Wang Qiwei State Key LabNA
Pediatr Res Pediatric res NA Dangoni Gustavo D Human Genome NA
Ann Clin Lab SAnnals of clinNA Shin Donghyun Department of NA
Gene Gene NA Mezzi Nessrine Laboratory ofNA
J Genet GenoJournal of ge NA Hu Ting Department of NA
NeuropediatriNeuropediatriNA Franquelim Catarina Pediatria, Ho NA
Am J Hum GeAmerican jourNA Paul Maimuna S Department of NA
JBJS Case ConJBJS case conNA Altaf Mir Tariq Department of NA
Mol NeurobioMolecular neNA Tolezano Giovanna Cant
Department of NA
Hum Genet Human genetiNA Alshammari Muneera J Department of NA
Prenat Diagn Prenatal diagNA Kirschen Gregory W Division of MNA
J Pathol The Journal oNA Yang Guoliang Department of NA
Am J Med Gen American jourNA Farooqui Sheeba Department of NA
Neurol GenetNeurology. GeNA Lee Cha Gon From the Depa NA
Front Genet Frontiers in gNA Huang Cheng Department of NA
Case Rep OphCase reports NA Sato Shigeru Department of NA
Mol Genet MMolecular genNA Berendes Lea-Sophie University of NA
Genome MedGenome mediNA Canavati Christina Department of NA
Mol CytogeneMolecular cytNA Lin Shaobin Prenatal DiagNA
J Assist Repr Journal of as NA Okutman O Universit&#x NA
Nat Hum BehNature humanNA Fei Chen-Jie Department of NA
Eur J Hum GeEuropean jourNA Poli M Cecilia Program for INA
Eur J Hum GeEuropean jourNA Traverso Monica Pediatric NeuNA
Sci Rep Scientific rep NA Higuchi Takashi Department of NA
Neurology Neurology NA Gould Laura From the NYUNA
Neurology Neurology NA Alkabie Samir From the Depa NA
BioinformaticBioinformaticNA Ng Jeffrey K Department of NA
Clin Chem Clinical chemiNA Strasser Bernhard Institute of NA
J Hematop Journal of h NA Karrs Jeremiah X Dartmouth Hea Jeremiah.X.Karrs@Hitchcock.org
Mol Biol Rep Molecular bioNA Hashemi SheiSomayeh Student ReseaNA
Neurol Neuroc Neurologia i NA Dulski Jaros&#x142 Department of Dulski.Jaroslaw@mayo.edu
CA Cancer J ClCA: a cancer jNA Casolino Raffaella Wolfson WohlNA
Front Genet Frontiers in gNA Wei Xianda Center for MeNA
Brain CommuBrain commun NA N&#xf3;bregaPaulo R Division of N NA
Heliyon Heliyon NA Zhang Shuning Department of NA
J Clin Endocr The Journal oNA Huybrechts Yentl Center of Med NA
Clin Genet Clinical genetNA Chen Yu-Jie Institute of NA
Hum GenomicHuman genom NA Khasawneh Lubna Q Department of NA
Sci Rep Scientific rep NA Liu Zhe Department of NA
NPJ Genom MNPJ genomic NA Mavura Yusuph Institute for Yusuph.Mavura@ucsf.edu
Zhonghua Yi XZhonghua yi xNA Yan Lulu Ningbo Women 775@163.com
Zhonghua Yi XZhonghua yi xNA Yin Xue PostgraduateNA
Zhonghua Yi XZhonghua yi xNA Liang Yeqiong Department of anyu@fudan.edu.cn
Zhonghua Yi XZhonghua yi xNA Zhou Fan Department of whlek6527@126.com
Zhonghua Yi XZhonghua yi xNA Li Zhi Department of liufanglafy@126.com
Zhonghua Yi XZhonghua yi xNA Liu Haoran Genetics Resexiaolichen@pumc.edu.cn
Hum Genet Human genetiNA Lord Jenny Human Develo NA
Front Med (L Frontiers in NA Thomasov&#xDana Institute of NA
Adv Sci (WeinAdvanced sci NA Li Xingran Chongqing Bra NA
Commun BiolCommunicatio NA Vasilescu Catalina Research ProgNA
Sci Rep Scientific rep NA Li Mengmeng National Clin NA
Pediatr NeuroPediatric neuNA McNamara R Colin Department of rcolinmcnamara@gmail.com
Ann Clin TranAnnals of clinNA Santana AlmaAlexandra Child NeuroloNA
Res Sq Research squNA Aplan Peter NA NA
medRxiv medRxiv : theNA Abidin Michael R MetropolitanNA
medRxiv medRxiv : theNA Panoyan Mary Anne NA NA
Sci Rep Scientific rep NA Baygin Rana Can Department of NA
J Appl Lab M The journal oNA Ji Yuan Department of NA
Sci Rep Scientific rep NA He Quan Department of NA
Sci Rep Scientific rep NA Zhang Ruiqi Department of NA
Cardiol YoungCardiology in NA Karmegaraj Balaganesh Sowmi Fetal he NA
Nat CommunNature commu NA MandiracioglBerk Department oNA
BMC Med Gen BMC medical NA ChetruengchaWanna Excellence CeNA
J Orthop SurgJournal of or NA Jiang Lejian Department of NA
BMC Pregnanc BMC pregnanc NA Gao Mengge NHC Key Labor NA
BMC CardiovaBMC cardiovas NA Jolfayi Amir GhaffariRajaie CardioNA
PLoS One PloS one NA Azimi Parisa NeuroscienceNA
J Exp Clin CanJournal of ex NA Lin Ying Department of NA
Prenat Diagn Prenatal diagNA Jaillard Alienor Department of NA
J Ultrasound Journal of ultNA Wu Siqi Department of NA
Genet Med Genetics in me NA Mordaunt Dylan A Health Econom NA
Am J Med Gen American jourNA Ram&#xed;reJuli&#xe1;n Hospital Unive NA
Front Genet Frontiers in gNA Geng Zilong Key LaboratorNA
Front Genet Frontiers in gNA Gayed Matthew M Division of MNA
Biochim BiophBiochimica etNA Cheng Ye Children's HoNA
Prenat Diagn Prenatal diagNA Verscaj Courtney P Division of N NA
Heliyon Heliyon NA Tang Xianglian Genetic and M NA
Heliyon Heliyon NA Zhang Qiang Joint Laborat NA
Front Genet Frontiers in gNA Kheriji Nadia Laboratory ofNA
Prenat Diagn Prenatal diagNA Dai Xiaohui Department of NA
J Endocrinol IJournal of endNA Zhao Yu Xing Key LaboratorNA
Gene Gene NA Sultan Tipu Department of NA
Pathol Res PrPathology, reNA Chen Bo-Jung Department of NA
BMJ Case RepBMJ case repoNA Ks Aswanth Paediatrics, ANA
Prenat Diagn Prenatal diagNA Walsh Caroline J The UniversitNA
Neurol Sci Neurological sNA de Souza Guilherme CaMedical Genet NA
Genet Med Genetics in me NA Hannes Laurens Department oNA
Genet Med Genetics in me NA Scala Marcello Department of NA
Prenat Diagn Prenatal diagNA Rothschild Harriet T School of MediNA
Am J Med Gen American jourNA Hills Sonia Division of G NA
Thromb HaemThrombosis aNA Bandini Perla Laboratori d NA
Clin Oral InveClinical oral NA Semjid Dejidnorov Department of NA
Mol Genet G Molecular geNA Deng Tianqin ReproductiveNA
Cureus Cureus NA Garg Arnesh Sri Ramachand NA
Front Genet Frontiers in gNA Louw Nadja Division of H NA
Am J Med Gen American jourNA Makhamreh Mona M Department oNA
Zhonghua Er KZhonghua er ke NA Yang P School of MedNA
Kidney Int Kidney internNA Riedhammer Korbinian M Institute of NA
Prog NeuropsProgress in n NA Pan Chuyu Key LaboratorNA
Yonsei Med JYonsei medicaNA Oh Jiyoung Division of Cl NA
EBioMedicineEBioMedicineNA Li Niu Department of NA
Invest OphthaInvestigative NA Li Xueqing State Key LabNA
Mol NeurobioMolecular neNA Ashaat Engy A Clinical Gene ea.ashaat@nrc.sci.eg
Mol Biol Rep Molecular bioNA Mir Yaser Rafiq Department of NA
Nucleic AcidsNucleic acids NA Du Haowei Department oNA
Am J Med Gen American jourNA Yu Yinhui Eye Center, TNA
Mol Biol Evol Molecular bioNA Lucas-S&#xe1Marcel DepartamentNA
Front PediatrFrontiers in pNA Wang Yi-Wei Division of P NA
Electrolyte B Electrolyte & NA Lee Seung Heon Department of NA
Front EndocriFrontiers in NA Weiss Birgit Institute of NA
Front EndocriFrontiers in NA Alzahrani Ali S Department of NA
Zhongguo FeiZhongguo fei NA a Xu Youtao Department of NA
Clin Chim ActClinica chimicNA Anitha Kuttiappan Department oNA
Cell Mol NeurCellular and NA Sesen Julie Vascular Biol NA
DevelopmentDevelopmentNA Tsai Meng-Han Department oNA
Am J Med Gen American jourNA De Falco Alessandro Department of NA
Pediatr TransPediatric tra NA Warasnhe Khaled Department of NA
Front ImmunoFrontiers in NA Shah Ravi K Department of NA
Mol Genet MMolecular genNA Du Runxuan Department of NA
Front EndocriFrontiers in NA Tan Hang-Jing Institute of NA
Neurol GenetNeurology. GeNA Ryan Marie From the Acade NA
Front Med (L Frontiers in NA Pang Lu Department of NA
Heliyon Heliyon NA Wang Tian Department of NA
Clin Genet Clinical genetNA Kamarck Marissa L Monell Chemic NA
Mov Disord Movement diso NA Zhang Jin Children's HoNA
Ann Clin TranAnnals of clinNA Shi YuZhi Department of NA
Clin Genet Clinical genetNA Xu Shuai School of Lif NA
In Vivo In vivo (Athe NA Su Pen-Hua Department of NA
Prenat Diagn Prenatal diagNA Li Ming-Wei Department of NA
Cancer Res TrCancer resea NA Ahn Bokyung Department of NA
Mol Genet G Molecular geNA Whitford Whitney School of Bio NA
Mol Genet G Molecular geNA Jiang Keke Department oNA
Appl Clin GenThe applicatioNA von Korn Hubertus Department of NA
Mol Genet G Molecular geNA Valent&#xed;F&#xe1;tima GastroenterolNA
Pediatr Aller Pediatric all NA Rayzan Elham Division of P NA
Exp Eye Res ExperimentalNA Chen Chonglin State Key LabNA
ParkinsonismParkinsonismNA Novis Luiz Eduardo P&#xf3 luizeduardonovis@hotmail.com
Cancer CommCancer commu NA Liu Weiren Department of NA
Kidney Int Kidney internNA Neves Precil D Division of N NA
Eur J Med GeEuropean jourNA Di Caprio Antonella Post-graduateantone.dicaprio@gmail.com
Br J Cancer British journaNA Nirgude Snehal Division of H NA
Biol PsychiatrBiological psyNA Wilkerson Matthew D Center for MiNA
J Int Med ResThe Journal oNA Zhang Ya'nan College of Tr NA
Eur J Obstet European jourNA Lin Xiao-Mei Prenatal DiagNA
Neuro Oncol Neuro-oncoloNA Appin Christina L University of NA
Int J Mol Sci International NA Kalm&#xe1;r Tibor Department of NA
J Pers Med Journal of pe NA Kien Nguyen TrungFaculty of MeNA
Genes (Basel)Genes NA Gonzalez-SaliFernando Tecnologico dNA
Genes (Basel)Genes NA Kovanda Anja Clinical Inst NA
Genes (Basel)Genes NA Guadagnolo Daniele Department of NA
Genes (Basel)Genes NA Serag Mounir Service de G NA
Genes (Basel)Genes NA GambadauroAntonella Department of NA
J Mol NeuroscJournal of moNA Dong Liling Neurology Dep NA
Sci Rep Scientific rep NA Tillmanns Niklas Brain Tumor RNA
Cancer Gene Cancer gene NA Zhang Shubing Department of NA
Am J Med Gen American jourNA Liaqat Khurram Department of NA
Life Sci Life sciences NA DhanushkumaT Department of NA
Comput Biol Computers inNA Shojaei Mona Cancer System NA
Seizure Seizure NA Zhang Xin Postgrad TraiNA
Medicine (BalMedicine NA Qi Yang-Fan Changchun Uni NA
Reprod Sci ReproductiveNA Evans Mark I Fetal Medici evans@compregen.com
Curr Issues MoCurrent issueNA Kim Danyeong Department oNA
Biology (BaselBiology NA Waung Maggie W Division of G NA
Healthcare (BHealthcare (BNA Seaby Eleanor G Human Develo NA
Audiol Res Audiology resNA Tesolin Paola Department of NA
Neurooncol ANeuro-oncoloNA Verduin Maikel Department of NA
World J Clin World journalNA Gao Chun-Fang Department of NA
Cureus Cureus NA Bakheet Kholoud Pediatrics, K NA
BMC Med Gen BMC medical NA Ghasemi Serwa Department of NA
Oral Dis Oral diseasesNA Xing Qin Center for MeNA
J Clin ImmunoJournal of cl NA Staines-BoonAid&#xe9; TaImmunology Se NA
Sci Rep Scientific rep NA Kim Jaewon Department of NA
Transl PsychiaTranslational NA Soueid Jihane Department of NA
Brain Dev Brain &amp; NA Hosseinpour Sareh Department of NA
Hum Mol GenHuman molecu NA KhosrowabadElham Department of NA
Brain Brain : a jour NA Singh Amrita K Department of NA
Int J HematolInternational NA Zheng Jiajia Department of NA
J Neurol Journal of ne NA Krenn Martin Department of NA
Elife eLife NA Jin Hui-Juan Key LaboratoryNA
Front Neurol Frontiers in NA Witzel Maximilian GMGZ MediziniNA
Front PediatrFrontiers in pNA Kuan Janene Department of NA
Front Genet Frontiers in gNA &#x15e;ahin Ay&#xe7;a Suna and &#xNA
Heliyon Heliyon NA AngelopoulouEleni Laboratory ofNA
Mov Disord Movement diso NA Kamath Sneha D Department of NA
J Med Genet Journal of meNA Koene Saskia Department of s.koene@lumc.nl
Genes ImmunGenes and imNA Uslu Kubra Department of NA
RMD Open RMD open NA Miao Junke Department of NA
Am J Hum GeAmerican jourNA Salpietro Vincenzo Department of NA
PLoS One PloS one NA Urcuyo Javier C MathematicalNA
Retina Retina (PhiladNA Huang Li State Key LabNA
JAMA Netw OJAMA networNA Zagami Paola Lineberger CoNA
Genes GenomGenes &amp;NA He Liting Department of NA
Am J Surg PatThe AmericanNA de la FoucharArnaud INSERM 1052,NA
Am J Med Gen American jourNA Goldfarb YaacRacheli Genetics InstiNA
Int Med Case International NA Liu Boce Department of NA
Front ImmunoFrontiers in NA Burleigh Alice Infection, Im NA
Br J HaematolBritish journ NA Akkus Erman Department of NA
Medicine (BalMedicine NA Li Zhang The Second AffNA
BMC Med Gen BMC medical NA Liu Danhua The ResearchNA
J Assist Repr Journal of as NA Wang Meng ReproductiveNA
Eur J Hum GeEuropean jourNA Pande Shruti Department of NA
Lung Cancer Lung cancer NA Wang Lei Department of NA
Eur J Obstet European jourNA Liu Jingyu Department of NA
Lab Med Laboratory mNA Sadeghipour Parham CardiovasculaNA
J Neurol Journal of ne NA Libonati Laura Department of laura.libonati@uniroma1.it
Cancer Med Cancer medicNA Gao Zhaoya Department of NA
Mol Genet G Molecular geNA Xin Bin Department of NA
Int J Ophthal International NA Luo Hong-Dou Affiliated Ey NA
Int J Ophthal International NA Zhang Shuang People's HospNA
Front PediatrFrontiers in pNA Ru Like School of PedNA
Prenat Diagn Prenatal diagNA Seed Emma Maternal FetaNA
BMC Med Gen BMC medical NA Cheng Chen Ultrasound DiNA
BMC Pediatr BMC pediatriNA Gong Yao Department of NA
Nat CommunNature commu NA Murphy Andrew J Department of andrew.murphy@stjude.org
Prenat Diagn Prenatal diagNA Rodriguez-ReLaia Biochemistry NA
Gene Gene NA Jing Sili Shaanxi Eye HoNA
Gene Gene NA Miao Mingzhu Department of NA
Pril (Makedo Prilozi (Make NA Teov Bojan University ChNA
Clin Genet Clinical genetNA Hordyjewska-Ewa Laboratory foNA
Child Neurol Child neuroloNA Garavatti Emily NeurodevelopNA
Ann PancreatAnnals of panNA Shao Yingkuan Key LaboratorNA
Zhejiang Da XZhejiang da xNA Wu Xinghan Department oNA
Zhejiang Da XZhejiang da xNA Zheng Yi Department of 22318424@zju.edu.cn
Zhejiang Da XZhejiang da xNA Lin Jingqi Central LaborNA
NeurogeneticNeurogeneticNA Abramowicz St&#xe9;pha Department ostephane.abramowicz@outlook.com
Mod Pathol Modern pathol NA Wei Shuanzeng Department of weishuanzeng@hotmail.com
J Mol Diagn The Journal oNA SoRelle Jeffrey A Whole ExomeNA S
Am J Med Gen American jourNA Freiman Andrew Genetic CounsNA
BMC GenomicBMC genomicNA Zong Liang Wuhan BGI TeNA
Eur J Hum GeEuropean jourNA Coetzer Kimberly ChriDivision of MNA
J Hum Genet Journal of hu NA Kawakami Ryota Department of NA
Eur J Med GeEuropean jourNA Al Jabry Tariq Department of NA
Proc Natl AcadProceedings oNA Yang Hong Wei Department of NA
J Clin ImmunoJournal of cl NA Lanz Anna-Lisa Division of P NA
J Clin ImmunoJournal of cl NA Riestra Maria Rodrig Laboratory ofNA
Mol Med RepMolecular med NA Lu Yiting Department of NA
Front Cardio Frontiers in NA Xu Xin Department of NA
Front Genet Frontiers in gNA Rimoldi Martina Neuromuscular NA
Breast CancerBreast cancerNA Cheng Han-Fang Comprehensive NA
Genome MedGenome mediNA AlAbdi Lama Department of NA
BMC Med Gen BMC medical NA Dantsev Ilya S Veltischev ReNA
BMC Pediatr BMC pediatriNA Chen Xiaoxue Department of NA
Eur J Hum GeEuropean jourNA PanagiotakakiEleni Department of NA
Child Care HeChild: care, NA Klitzman Robert Psychiatry anNA
Blood Blood NA Bendapudi Pavan K Beth Israel D NA
PLoS One PloS one NA Brauner Raja Pediatric EndNA
Invest OphthaInvestigative NA Gu Xiang Department of NA
Iran J Med SciIranian journaNA Mansouri Nasrin Department of NA
Mol Genet G Molecular geNA Alonso-Luna Oscar Programa de N MA
Genome MedGenome mediNA Xiao Hui Department of NA
BioinformaticBioinformaticNA Vozza Gianluca Department of NA
Am J Hum GeAmerican jourNA Torene Rebecca I GeneDx, GaitNA
Ophthalmic ROphthalmic rNA Kim Dong Ju NA NA
Ophthalmic ROphthalmic rNA Zhou Biting NA NA
Prenat Diagn Prenatal diagNA Nguyen Thi Sim Fetal Interve NA
Front NeuroscFrontiers in NA Ou Ruwei Department of NA
Front PediatrFrontiers in pNA Li Xianhong Department of NA
Pathol Oncol Pathology oncNA Zhang Caixin Department of NA
Neurooncol ANeuro-oncoloNA N&#xf8;r&#xfDorte Schou Department oNA
J Clin Res PedJournal of cli NA Cai Wenjuan Department of NA
Clin Genet Clinical genetNA Nazmina Gul Department of NA
Epilepsia Epilepsia NA Coppola Antonietta Department of NA
Mol Genet G Molecular geNA Licchetta Laura IRCCS Istitut NA
Genes ChromGenes, chromNA Hormann Femke M Princess M&#NA
Mol Genet G Molecular geNA Li Jiayi First School NA
Gynecol OncoGynecologic NA Gordinier Mary E Norton Cancer mary.gordinier@nortonhealthcare.o
JCO Glob OncJCO global onNA Tanwar Nishtha AjitS basecare Onco NA
Clin Lab Clinical labor NA Fu Chunyan NA NA
J Pediatr End Journal of pe NA Dokurel &#xc7&#x130;pek Department of NA
J Cell Bioche Journal of celNA Xiao Xiaoqiang Joint ShantouNA
Cancer Sci Cancer sciencNA Tamura Daichi Department of NA
Mol Genet G Molecular geNA Zhang Jiamei Henan Key Lab NA
Am J Med Gen American jourNA Jelin Angie C Department of NA
BMC Med Gen BMC medical NA Yan Lulu The Central LNA
OphthalmoloOphthalmoloNA Feng Zhao Xun Department of NA
Indian J PediaIndian journalNA Wander Arvinder Division of ChNA
Calcif Tissue ICalcified tiss NA Thapa Rupesh The UniversitNA
Mol Genet MMolecular genNA P&#xfc;hringeManuel Department of NA
Noro PsikiyatNoro psikiyatrNA Alp An&#x131;l Hacettepe UniNA
World J GastrWorld journalNA Jiang Ning-Zu The First Cli NA
medRxiv medRxiv : theNA Kolekar Pandurang NA NA
bioRxiv bioRxiv : the NA Kim Jung Division of C NA
medRxiv medRxiv : theNA Liu Jun Nuffield DepaNA
Bone Rep Bone reports NA Marchionni Enrica Medical Genet NA
J Clin Exp HepJournal of cl NA Sharma Shruti Pediatric GasNA
Front Genet Frontiers in gNA Finocchi Andrea Research UnitNA
Front Genet Frontiers in gNA Wang You The First Sch NA
Front Genet Frontiers in gNA Lin Chih-Hsiang Department of NA
Front Genet Frontiers in gNA Fang Yuan Department of NA
Front NeuroscFrontiers in NA Wu Yong Medical ReseaNA
Front EndocriFrontiers in NA De Sousa Sunita M C Endocrine & NA
Front EndocriFrontiers in NA Zhou Lin Department of NA
Brain CommuBrain commun NA Yalcouy&#xe9Abdoulaye Facult&#xe9 NA
World J Clin World journalNA Zhang Li-Jie Xuzhou Medica NA
Front Neurol Frontiers in NA Zhu Hui Department of NA
Mol Genet G Molecular geNA Xu Huiling Department oNA
Mol Genet G Molecular geNA Tian Runyi Center for MeNA
Hum Mol GenHuman molecu NA Chen Desmond ZeyProgram in GeNA
Andrology Andrology NA Khan Muhammad RDepartment of NA
J Genet Journal of genNA Castano-JaramLina M Clinical ImmuMexico.dr.lugo.reyes@gmail.com
Epilepsia Epilepsia NA Kim Se Hee Division of P NA
Intern Med Internal mediNA Ito Miwa Department of NA
Cardiovasc PaCardiovascular NA Ichimata Shojiro Department of NA
Eur J Obstet European jourNA Yu Qiu-Xia Prenatal DiagNA
J AutoimmunJournal of au NA Reuschl&#xe9Quentin Laboratoire NA
Zhongguo ShiZhongguo shiNA Li Qing-Zhao Department oNA
Eur J Med GeEuropean jourNA Sonoda Yuri Department of NA
Mol Genet G Molecular geNA Zhao Ya Department of NA
Int J Mol Sci International NA W&#x119;&#x Michalina Department of NA
Int J Mol Sci International NA Zhou Wenhui State Key LabNA
Int J Mol Sci International NA Delas Flora Institute of MNA
Cancers (BaseCancers NA Wei Christina Hsi Department oNA
Cancers (BaseCancers NA Moreno Carlos S Department of NA
Cancers (BaseCancers NA Wang Haiyue Key LaboratorNA
BMC Med Gen BMC medical NA Wang Jie Department of NA
Clin Auton ReClinical autonNA de C&#xe1;ssRita Molecular PhyNA
Prenat Diagn Prenatal diagNA Allen Stephanie K West Midlands NA
Genet Med Genetics in me NA Deng Joseph Clinical GenetNA
Exp Biol MedExperimentalNA Li Dan Division of B NA
Congenit AnoCongenital a NA Yamoto Kaori Department oNA
Thyroid Thyroid : offi NA Hurst Zachary A Division of G NA
BMC Med Gen BMC medical NA Peng Ying Prenatal Diagpengyingpy@hotmail.com
NPJ ParkinsonNPJ ParkinsonNA Miltenberger-Gabriel Laborat&#xf3gmiltenyi@medicina.ulisboa.pt
Ann DermatolAnnals of de NA G&#xfc;lner Elif Kele&#x1Department of elifkeles.dr@gmail.com
Int J Biol Ma International NA Wang Yan Department of NA
Cureus Cureus NA Alasmari Badriah G Department of NA
Arch DermatoArchives of d NA Chegini Mitra Department of NA
Prenat Diagn Prenatal diagNA Willison Clare North ThamesNA
Mol SyndromMolecular sy NA Uctepe Eyyup Acibadem Anka NA
Mol SyndromMolecular sy NA Rafat Karima Clinical Gene NA
Mol SyndromMolecular sy NA Civelek &#xdcBurcu Pediatric MetNA
Mol SyndromMolecular sy NA Bilal Muhammad Department of NA
Mol SyndromMolecular sy NA Ghasemi Aida Genetics ReseNA
Mol SyndromMolecular sy NA Kocagil Sinem Department of NA
Mol SyndromMolecular sy NA Roudbari Faranak Department of NA
Cureus Cureus NA Taboun Zahra Medicine, SchNA
Zhonghua Bing Zhonghua bing NA Wen Z Department of NA
Am J Med Gen American jourNA Bai Ting Department of NA
Mol CytogeneMolecular cytNA Qin Shengfang Department of qinshengfang@126.com
BMC Pulm MBMC pulmonaNA Peng Yan Oncology Depa NA
Nat Genet Nature genetiNA Guo Michael H Department of NA
Sci Rep Scientific rep NA Sarker Shaoli Genetics and NA
Sci Rep Scientific rep NA Kong Xiao-Fei Division of D fei.kong@utsouthwestern.edu
Nat CommunNature commu NA Wang Sheng Department of NA
Transl PsychiaTranslational NA Jiang Miaomiao National CliniNA
Prenat Diagn Prenatal diagNA Sonner Sarah Centre for PubNA
Cytogenet G Cytogenetic NA Brea-Fern&#xAlejandro J NA NA
J Clin Oncol Journal of cli NA Noerenberg Daniel Department oNA
Prenat Diagn Prenatal diagNA Blayney Gillian V Fetal MedicinNA
Genet Med Genetics in me NA Maroofian Reza Department of r.maroofian@ucl.ac.uk
EXCLI J EXCLI journalNA Chermakani Prakash Department of NA
Gynecol OncoGynecologic oNA Kojima Yuki Department of NA
Front PediatrFrontiers in pNA Wen Yuting Department of NA
Front Cardio Frontiers in NA Yang Huan Department of NA
Front Genet Frontiers in gNA Gao Dehua Department of NA
Mol Genet MMolecular genNA Kalay Irem Institute of NA
Mol Genet MMolecular genNA Lail Gurnoor Division of C NA
Mol Genet MMolecular genNA Aoki Eriko Glycan &ampNA
J Clin Pathol Journal of cli NA LauhasurayotSupanun Department of NA
BMC Pediatr BMC pediatriNA Dong Lili Department of NA
Eur J Hum GeEuropean jourNA Dong Shuqian Department of NA
Mol Cancer TMolecular canNA Arribas Alberto J Institute of ONA
PLoS One PloS one NA Vodnjov Nina Clinical Insti NA
Cancer EpideCancer epidem NA Petrykey Kateryna Universit&#x NA
Cell CommunCell communic NA Huang Limin Department of NA
Blood Blood NA Schuster Stephen J Lymphoma Prog NA
J Neurosurg CJournal of ne NA Marin Bianca M School of MedNA
Front PediatrFrontiers in pNA Muthaffar Osama Y Department of NA
Drug Des DevDrug design, NA Zhang Qiying Department of NA
Arch RheumatArchives of r NA Tokgun Pervin Elvan Department of NA
Res Sq Research squNA Chen Fangyi Department of NA
medRxiv medRxiv : theNA Zhong Yuanxin NA NA
Heliyon Heliyon NA Gao Chunlai Children's HoNA
Gene Gene NA Zeng Ming Department of NA
J Mycol Med Journal de myNA Ma Na Key LaboratorNA
J Neurol NeurJournal of ne NA Dohrn Maike F Dr. John T. MNA
Mol Genet G Molecular geNA Rosina Erica Laboratory ofNA
Mol Biol Rep Molecular bioNA Ullah Asad Institute of NA
Cancer Cell Cancer cell NA Chang Jiang Department of changjiang815@hust.edu.cn
Oral Oncol Oral oncologyNA Bibee Kristin P Department of kbibee1@jhmi.edu
 Database Dataset AcessType of AssayNo of SampleGender Isolation SourGeogrpahic Location
NCBI SRA PRJNA926612Whole genome 286 BioSample
NCBI SRA na
na

hannes.krankenberg@charite.de

elkc@ccu.edu.tw
berto.tozzi@unipd.it

ref.tuncer@istanbul.edu.tr

angdanxue@163.com

9825@mail.cmuh.org.tw

anWagensveld@iknl.nl

naushabah@gmail.com

enek.travnicek@upol.cz
egory.gressel@corewellhealth.org
wc091@ha.org.hk

nterrainer@mednet.ucla.edu

zabeth.szamreta@merck.com

rika.yumru@istanbul.edu.tr
arine.renier@unicaen.fr
arkice818@163.com

nfu@tmu.edu.cn

mes.sarah1@mayo.edu

weigelt@googlemail.com

aris@icans.eu

qin2018@126.com
iara.auwerx@unil.ch

959779688@163.com

otoko.kanno@jfcr.or.jp
akahashi@jichi.ac.jp

plee77@hku.hk
ahi.Maryam@mayo.edu

m765@duke.edu
exandra.lebras@nature.com

mzsakine@gmail.com
enjiayaozsyy@163.com

sherm@infertile.com

ovanni.innella2@unibo.it

risata@ku.edu.tr

ngxue1116@126.com

a.wadi@duke.edu

bine.heublein@med.uni

neta.slyk@wum.edu.pl

payton@amgen.com
dav.siddhartha@mayo.edu

dith.altmann@charite.de

edronlewis@gmail.com
ju.murayama.s8@dc.tohoku.ac.jp
thlady01@gmail.com
anjohn@sutterhealth.org
ttalorusso@libero.it

seermuhammad02@gmail.com

iko.abe@jfcr.or.jp
70558385@163.com

aurahannon@gmail.com

ng.nirali@gmail.com

ayimin627@hotmail.com
ter.sidaway@nature.com

cole.Topalov@med.uni
artinangeles22@hotmail.com

ara.nicgiollachomhaill@hse.ie

kwon94@knu.ac.kr

tesma@tcd.ie

gani.giorgio@gmail.com
elbairi@ump.ac.ma
uise.am.benoit@gmail.com

useppevizzielli@yahoo.it

nka.zebic@sydney.edu.au

Agusti@mdanderson.org

an@126.com

zengyou66@hotmail.com

edermann@ucl.ac.uk
bb.hollis@ed.ac.uk

ucesf@wustl.edu

engaosh@mail.sysu.edu.cn

lnaggar@natera.com
ena.tucker@mcri.edu.au
bb.hollis@ed.ac.uk
matsubayashi@scchr.jp

atteo.dugo@istitutotumori.mi.it

ola.concolino@policlinicogemelli.it

ng.liu@roswellpark.org

neris@dfci.harvard.edu
s.vannieuwenhuysen@uzleuven.be
arafie@yahoo.com

@dfci.harvard.edu

atal establishment of neuronal circuits in addition to prenatal cell survival, cell migration, and axon elongation, and its loss lead
ra.reda@salud.madrid.org

rreyf@stanleyresearch.org

lombine.meunier@ipg.be

ronika.vaclavik@fa2.ch
ykyta.artomov@nationwidechildrens.org

borah.salik@hubruxelles.be
remiah.X.Karrs@Hitchcock.org

ulski.Jaroslaw@mayo.edu

suph.Mavura@ucsf.edu
5@163.com

yu@fudan.edu.cn
hlek6527@126.com
fanglafy@126.com
aolichen@pumc.edu.cn
olinmcnamara@gmail.com
.ashaat@nrc.sci.eg
zeduardonovis@hotmail.com

tone.dicaprio@gmail.com

ans@compregen.com
oene@lumc.nl

ura.libonati@uniroma1.it

drew.murphy@stjude.org
318424@zju.edu.cn

ephane.abramowicz@outlook.com
eishuanzeng@hotmail.com
ary.gordinier@nortonhealthcare.org

exico.dr.lugo.reyes@gmail.com
 ngyingpy@hotmail.com
miltenyi@medicina.ulisboa.pt
fkeles.dr@gmail.com

nshengfang@126.com

.kong@utsouthwestern.edu
maroofian@ucl.ac.uk

angjiang815@hust.edu.cn
ibee1@jhmi.edu
eogrpahic Location
axon elongation, and its loss leading to malformation of cortical development and severe epilepsy Noriko Homma, Ruyun Zhou
lepsy Noriko Homma, Ruyun Zhou, Muhammad Imran Naseer, Adeel G. Chaudhary, Mohammed Al-Qahtani, Nobutaka Hirokaw
ed Al-Qahtani, Nobutaka Hirokawa O3 Integration of metagenomics and metabolomics in gut microbiome research Maryam G
microbiome research Maryam Goudarzi, Albert J. Fornace Jr. O4 A unique integrated system to discern pathogenesis of centra
to discern pathogenesis of central nervous system tumors Saleh Baeesa, Deema Hussain, Mohammed Bangash, Fahad Algham
hammed Bangash, Fahad Alghamdi, Hans-Juergen Schulten, Angel Carracedo, Ishaq Khan, Hanadi Qashqari, Nawal Madkhali, M
nadi Qashqari, Nawal Madkhali, Mohamad Saka, Kulvinder S. Saini, Awatif Jamal, Jaudah Al-Maghrabi, Adel Abuzenadah, Adeel
aghrabi, Adel Abuzenadah, Adeel Chaudhary, Mohammed Al Qahtani, Ghazi Damanhouri O5 RPL27A is a target of miR-595 and
RPL27A is a target of miR-595 and deficiency contributes to ribosomal dysgenesis Heba Alkhatabi O6 Next generation DNA sequ
abi O6 Next generation DNA sequencing panels for haemostatic and platelet disorders and for Fanconi anaemia in routine diag
r Fanconi anaemia in routine diagnostic service Anne Goodeve, Laura Crookes, Nikolas Niksic, Nicholas Beauchamp O7 Targeted
Nicholas Beauchamp O7 Targeted sequencing panels and their utilization in personalized medicine Adel M. Abuzenadah O8 Int
dicine Adel M. Abuzenadah O8 International biobanking in the era of precision medicine Jim Vaught O9 Biobank and biodata fo
aught O9 Biobank and biodata for clinical and forensic applications Bruce Budowle, Mourad Assidi, Abdelbaset Buhmeida O10
Assidi, Abdelbaset Buhmeida O10 Tissue microarray technique: a powerful adjunct tool for molecular profiling of solid tumors Ja
lecular profiling of solid tumors Jaudah Al-Maghrabi O11 The CEGMR biobanking unit: achievements, challenges and future pla
ements, challenges and future plans Abdelbaset Buhmeida, Mourad Assidi, Leena Merdad O12 Phylomedicine of tumors Sudhir